[go: nahoru, domu]

US20020012971A1 - PCR compatible nucleic acid sieving medium - Google Patents

PCR compatible nucleic acid sieving medium Download PDF

Info

Publication number
US20020012971A1
US20020012971A1 US09/792,297 US79229701A US2002012971A1 US 20020012971 A1 US20020012971 A1 US 20020012971A1 US 79229701 A US79229701 A US 79229701A US 2002012971 A1 US2002012971 A1 US 2002012971A1
Authority
US
United States
Prior art keywords
pcr
polymer
polymer solution
sieving medium
sieving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/792,297
Inventor
Tammy Mehta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Caliper Life Sciences Inc
Original Assignee
Caliper Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caliper Technologies Corp filed Critical Caliper Technologies Corp
Priority to US09/792,297 priority Critical patent/US20020012971A1/en
Assigned to CALIPER TECHNOLOGIES CORP. reassignment CALIPER TECHNOLOGIES CORP. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MEHTA, TAMMY BURD
Publication of US20020012971A1 publication Critical patent/US20020012971A1/en
Priority to US10/659,423 priority patent/US7521186B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]

Definitions

  • Manipulating fluidic reagents and assessing the results of reagent interactions are central to chemical and biological science. Manipulations include mixing fluidic reagents, assaying products resulting from such mixtures, separation or purification of products and reagents, and the like. A single experiment may involve hundreds of fluidic manipulations, product separations, recording processes and the like, each of which involve different types of laboratory equipment and conditions.
  • PCR polymerase chain reaction
  • microscale devices for high throughput mixing and assaying small fluid volumes have been developed. See, e.g., Parce et al., U.S. Pat. No. 5,942,443, “High Throughput Screening Assay Systems in Microscale Devices,” which provides pioneering technology related to microscale devices.
  • U.S. Ser. No. 09/093,832 by Burd Mehta et al. “Microfluidic Matrix Localization Apparatus and Methods,” provides methods of performing PCR and nucleic acid separations in the same microfluidic device.
  • Improved methods for performing PCR and nucleic acid separations including improved sieving mediums are desirable, particularly those which take advantage of high-throughput, low cost microfluidic systems.
  • the present invention provides these and other features by providing nucleic acid sieving mediums, methods of performing PCR and nucleic acid separations along with high throughput microscale systems and many other features that will be apparent upon complete review of the following disclosure.
  • the present invention provides nucleic acid sieving mediums, microfluidic devices, and methods for performing nucleic acid separations and PCR.
  • the sieving mediums provided are compatible with both nucleic acid separations and PCR because they provide baseline nucleic acid separation and do not inhibit PCR.
  • a microfluidic device for performing both PCR and nucleic acid separations.
  • the device comprises at least one microscale channel and a sieving medium.
  • the sieving medium is disposed within the at least one microscale channel and comprises a polymer solution, which polymer solution comprises less than about 0.5% polymer, less than about 0.4% polymer, or about 0.35% polymer or less.
  • Typical polymers include acrylamide, such as linear acrylamide, polyacrylamide, polydimethylacrylamide, polydimethylacrylamide/coacrylic acid, and the like.
  • Other polymers include, but are not limited to, agarose, methyl cellulose, polyethylene oxide, hydroxycellulose, hydroxy ethyl cellulose, and the like.
  • the devices also optionally comprise one or more proteins, nucleic acids, PCR reaction components, or PCR products disposed within the at least one microfluidic channel.
  • PCR reaction components include, but are not limited to, a polymerase, e.g., a thermostable DNA polymerase, a plurality of nucleotides, a nucleic acid template, a primer which hybridizes to the nucleic acid template, and Mg ++ .
  • the method comprises providing two or more polynucleotides and a sieving medium.
  • the polynucleotides typically comprise one or more PCR products, RNA, or DNA.
  • the sieving medium typically comprises a polymer solution as described above. The two or more polynucleotides migrate through the sieving medium, thereby separating the two or more polynucleotides.
  • the sieving medium is introduced into a microfluidic channel and the two or more polynucleotides migrate through the sieving medium in the microfluidic channel.
  • the two or more polynucleotides are optionally separated by electrophoresis in the sieving medium.
  • methods of performing PCR and separating one or more PCR products comprise mixing one or more PCR reaction component as described above with a sieving medium to provide a PCR sieving medium, wherein the sieving medium comprises a polymer solution as described above.
  • the PCR sieving medium is then thermocycled to produce one or more PCR products, which are separated by flowing in the sieving medium.
  • PCR is performed in a microfluidic device by mixing the PCR reaction components with the sieving medium in a microfluidic channel.
  • the one or more PCR products are separated, e.g., electrophoretically, by flowing the one or more PCR products through the sieving medium in the microfluidic channel.
  • nucleic acid sieving mediums comprise one or more polynucleotides, such as DNA, RNA, PCR products, or the like, one or more PCR reagents as described above, and a polymer solution as described above.
  • FIG. 1 is a schematic drawing of a microfluidic device for performing PCR and nucleic acid separations.
  • FIG. 2 is a schematic drawing of a microchannel for joule heating.
  • FIG. 3 is a graph providing nucleic acid separation data obtained in a sieving medium comprising 0.35% polymer.
  • DNA separations are normally performed in sieving mediums that have a certain concentration of sieving medium to achieve separation of various sizes of DNA fragments.
  • concentration of polymers used in sieving media typically inhibits the polymerase chain reaction (PCR), thereby preventing the two assays from being carried out in one medium.
  • the present invention provides a mixture compatible with PCR that also serves as a DNA separation medium.
  • the sieving mediums of the present invention comprise lower concentrations of polymer than are normally used to achieve DNA separation. The lower concentrations of polymer do not inhibit PCR and still provide separation of polynucleotides.
  • a typical sieving polymer concentration used in DNA separations is about 3%, e.g., 3% acrylamide. This concentration is known to inhibit polymerase chain reactions (PCR). However, lower levels of the same polymer are not inhibitory.
  • the present invention provides a PCR compatible mixture with a low amount of polymer used to suppress electroosmotic flow in the channels of a microfluidic device.
  • the concentration of polymer provided in the present invention is typically less than about 0.5%, more typically less than about 0.4% and preferably about 0.35% or less. Since this is below the usual threshold of sieving, the polymer here was initially used as an agent to eliminate bulk movement of the fluid by acting as a dynamic coating for the channel walls.
  • the present sieving medium also provided nucleic acid separations in the same low polymer medium in which PCR was performed. While, the exact mechanism of DNA sieving is not known, one advantage of the present medium is to provide a single fluid compatible with PCR and nucleic acid separations. Thus, the present invention provides, with a relatively simple loading or fabrication procedure, multi-step assays, e.g., PCR and subsequent product separation, using the present sieving medium.
  • the present invention provides a nucleic acid sieving medium compatible with nucleic acid separations and PCR as well as devices for performing nucleic acid separations and PCR, e.g., devices comprising a sieving medium with a low polymer concentration. Methods of separating nucleic acids and performing PCR using low concentration sieving mediums are also provided.
  • a nucleic acid sieving medium that is compatible with PCR and nucleic acid separations is provided.
  • the sieving medium comprises a low concentration of polymer, which low concentration does not inhibit PCR.
  • DNA is separated in sieving mediums with higher polymer concentrations than those provided herein.
  • nucleic acids are optionally separated using the lower polymer concentrations provided herein thereby providing methods for performing nucleic acid separation and PCR in the same medium.
  • the sieving medium typically comprises one or more polynucleotides, one or more PCR reagents, and a polymer solution, which polymer solution comprises less than about 0.5% polymer, less than about 0.4% polymer, or about 0.35% polymer or less.
  • the polymer solution is thereby used to provide PCR and nucleic acid separations in the same matrix.
  • the polymer solution is eliminated and optionally replaced with an electroosmotic flow suppressor.
  • the one or more PCR reaction components comprise one or more of: a thermostable polymerase, a thermostable DNA polymerase, a plurality of nucleotides, a nucleic acid template, a primer which hybridizes to the nucleic acid template, Mg ++ , and the like.
  • the one or more polynucleotides typically comprise DNA, RNA, or PCR products.
  • Typical polymer solutions of the invention comprise low concentrations of one or more of the following: acrylamide, agarose, methyl cellulose, polyethylene oxide, hydroxycellulose, hydroxy ethyl cellulose, or the like. Combinations of any of these polymers are also optionally used.
  • acrylamide Various types of acrylamide are used, including, but not limited to, linear acrylamide, polyacrylamide, polydimethylacrylamide, polydimethylacrylamide/coacrylic acid, or the like.
  • a wide variety of alternative sieving mediums are available, and are optionally used in methods of the invention, e.g., at low concentrations to provide a medium compatible with both PCR and nucleic acid separations.
  • a variety of sieving matrixes and the like are available from Supelco, Inc. (Bellefonte, Pa.; see, 1997 Suppleco catalogue).
  • Common matrixes which are useful in the present invention include those generally used in low pressure liquid chromatography, gel electrophoresis and other liquid phase separations; matrix materials designed primarily for non-liquid phase chromatography are also useful in certain contexts, as the materials often retain separatory characteristics when suspended in fluids.
  • Alternate separation matrix media include, but are not limited to, low pressure liquid chromatography media include, e.g., non-ionic macroreticular and macroporous resins which adsorb and release components based upon hydrophilic or hydrophobic interactions such as Amberchrom resins (highly cross-linked styrene/divinylbenzene copolymers suitable for separation of peptides, proteins, nucleic acids, antibiotics, phytopharmacologicals, and vitamins); the related Amberlite XAD series resins (polyaromatics and acrylic esters) and amberchroms (polyaromatic and polymethacrylates) (manufactured by Rohm and Haas, available through Suppleco); Diaion (polyaromatic or polymethacrylic beads); Dowex (polyaromatics or substituted hydrophilic functionalized polyaromatics) (manufactured by Dow Chemical, available through Suppleco); Duolite (phenol-formaldehy
  • Other electrophoresis media include silica gels such as Davisil Silica, E. Merck Silica Gel, Sigma-Aldrich Silica Gel (all available from Suppleco) in addition to a wide range of silica gels available for various purposes as described in the Aldrich catalogue/handbook (Aldrich Chemical Company (Milwaukee, Wis.)).
  • Preferred gel materials include agarose based gels, various forms of acrylamide based gels, Genescan polymers (reagents available from, e.g., Suppleco, SIGMA, Aldrich, SIGMA-Aldrich and many other sources), colloidial solutions such as protein colloids (gelatins) and hydrated starches.
  • colloidial solutions such as protein colloids (gelatins) and hydrated starches.
  • affinity media for purification and separation of molecular components are also available, including a variety of modified silica gels available from SIGMA, Aldrich and SIGMA-Aldrich, as well as Suppleco, such as acrylic beads, agarose beads, cellulose, sepharose, sepharose CL, toyopearl, or the like chemically linked to an affinity ligand such as a biological molecule.
  • modified silica gels available from SIGMA, Aldrich and SIGMA-Aldrich
  • Suppleco such as acrylic beads, agarose beads, cellulose, sepharose, sepharose CL, toyopearl, or the like chemically linked to an affinity ligand such as a biological molecule.
  • activated matrixes amino acid resins, avidin and biotin resins, carbohydrate resins, dye resins, glutathione resins, hydrophobic resins, immunochemical resins, lectin resins, nucleotide/coenzyme resins, nucleic acid resins, and specialty resins are available, e.g., from Suppleco, SIGMA, Aldrich or the like. See also, Hermanson et al. (1992) Immobilized Affinity Ligand Techniques Academic Press and optionally used in the channels of the invention.
  • the fluid polymerizes upon exposure to light (i.e., the fluid comprises a “photopolymerizable” polymer).
  • the fluid is then selectively exposed to light (e.g., using photomasking techniques) in those regions where a polymerized gel is desired.
  • Unpolymerized fluid is then optionally washed out of the unselected regions of the microfluidic device, or into a waste reservoir using electrokinetic flow or pressure.
  • free-radical polymerizable monomers photopolymerize to form gels, or can be made photopolymerizeable by the addition of, e.g., energy transfer dyes.
  • free-radical polymerizable monomers can be selected from acrylate, methacrylate and vinyl ester functionalized materials. They can be monomers and/or oligomers such as (meth)acrylates (meth)acrylamides, acrylamides, vinyl pyrrolidone and azalactones.
  • Such monomers include mono-, di-, or poly-acrylates and methacrylates such as methyl acrylate, methyl methacrylate, ethyl acrylate, isopropyl methacrylate, isooctyl acrylate, isobornyl acrylate, isobornyl methacrylate, acrylic acid, n-hexyl acrylate, stearyl acrylate, allyl acrylate, glycerol diacrylate, glycerol triacrylate, ethylene glycol diacrylate, diethyleneglycol diacrylate, triethyleneglycol dimethacrylate, 1,6-hexanediol diacrylate, 1,3-propanediol diacrylate, 1,3-propanediol dimethacrylate, trimethanol triacrylate, 1,2,4-butanetriol trimethylacrylate, 1,4-cyclohexanediol diacrylate, pentaerythritol triacrylate, pen
  • Strongly polar monomers such as acrylic acid, acrylamide, itaconic acid, hydroxyalkyl acrylates, or substituted acrylamides or moderately polar monomers such as N-vinyl-2-pyrrolidone, N-vinyl caprolactam, and acrylonitrile are also useful.
  • Proteins such as gelatin, collagen, elastin, zein, and albumin, whether produced from natural or recombinant sources, which are made by free-radical polymerization by the addition of carbon-carbon double or triple bond-containing moieties, including acrylate, diacrylate, methacrylate, ethacrylate, 2-phenyl acrylate, 2-chloro acrylate, 2-bromo acrylate, itaconate, oliogoacrylate, dimethacrylate, oligomethacrylate, acrylamide, methacrylamide, styrene groups, and other biologically acceptable photopolymerizable groups, can also be used, e.g., in low concentration, to form sieving matrixes.
  • moieties including acrylate, diacrylate, methacrylate, ethacrylate, 2-phenyl acrylate, 2-chloro acrylate, 2-bromo acrylate, itaconate, oliogoacrylate, dimethacrylate, o
  • Dye-sensitized polymerization is well known in the chemical literature.
  • light from an argon ion laser (514 nm) in the presence of an xanthin dye and an electron donor, such as triethanolamine, to catalyze initiation, serves to induce a free radical polymerization of acrylic groups in a reaction mixture (Neckers, et al., (1989) Polym. Materials Sci. Eng., 60:15; Fouassier, et al., (1991) Makromol. Chem., 192:245-260).
  • the dye After absorbing laser light, the dye is excited to a triplet state.
  • the triplet state reacts with a tertiary amine such as the triethanolamine, producing a free radical which initiates a polymerization reaction.
  • Polymerization is extremely rapid and is dependent on the functionality of the composition, its concentration, light intensity, and the concentration of dye and, e.g., amine.
  • Dyes are also optionally used which absorb light having a frequency between 320 nm and 900 nm, form free radicals, are water soluble, etc.
  • photosensitive dyes that are optionally used to optically initiate polymerization, such as ethyl eosin, eosin Y, fluorescein, 2,2-dimethoxy-2-phenyl acetophenone, 2-methoxy,2-phenylacetophenone, camphorquinone, rose bengal, methylene blue, erythrosin, phloxime, thionine, riboflavin, methylene green, acridine orange, xanthine dye, and thioxanthine dyes.
  • Cocatalysts useful with photoinitiating dyes are typically nitrogen based compounds capable of stimulating a free radical reaction.
  • Primary, secondary, tertiary or quaternary amines are suitable cocatalysts, as are nitrogen atoms containing electron-rich molecules.
  • Cocatalysts include triethanolamine, triethylamine, ethanolamine, N-methyl diethanolamine, N,N-dimethyl benzylamine, dibenzyl amine, N-benzyl ethanolamine, N-isopropyl benzylamine, tetramethyl ethylenediamine, potassium persulfate, tetramethyl ethylenediamine, lysine, ornithine, histidine and arginine.
  • Examples of the dye/photoinitiator system include ethyl eosin with an amine, eosin Y with an amine, 2,2-dimethoxy-2-phenoxyacetophenone, 2-methoxy-2-phenoxyacetophenone, camphorquinone with an amine, and rose bengal with an amine.
  • dye may absorb light and initiate polymerization, without any additional initiator such as an amine.
  • additional initiator such as an amine.
  • only the dye and a monomer need be present to initiate polymerization upon exposure to light. The generation of free radicals is terminated when the laser light is removed.
  • Some photoinitiators such as 2,2-dimethoxy-2-phenylacetophenone, do not require any auxiliary amine to induce photopolymerization; in these cases, the presence of dye, monomer, and an appropriate wavelength of light is sufficient for photopolymerization.
  • Preferred light sources include various lamps and lasers such as those which have a wavelength of about 320-800 nm.
  • This light can be provided by any appropriate source able to generate the desired radiation, such as a mercury lamp, longwave UV lamp, He-Ne laser, an argon ion laser, etc.
  • a UV source is used to polymerize a UV photopolymerizeable gel.
  • the light source used is typically selected based upon the chemistry which is to be affected by the source.
  • a variety of gels or polymers are selectively polymerized by exposure to heat.
  • selective heat control using applied current is easily performed in the microfluidic apparatus of the invention, providing for simplified control of gel polymerization through thermal processes. Examples include initiation by thermal initiators, which form free radicals at moderate temperatures, such as benzoyl peroxide, with or without triethanolamine, potassium persulfate, with or without tetramethylethylenediamine, and ammonium persulfate with sodium bisulfite.
  • the fluid is polymerized by selectively exposing it to an activator or cross-linker.
  • an activator or cross-linker for example, where the fluid is polyacrylamide, the activator/cross linker can be TEMED and/or APS.
  • the above polymers e.g., in solution format, gel format, or the like, and typically polymerized as described above, are typically used in microfluidic devices to provide devices useful for both PCR and separation of nucleic acids.
  • a mixture of polynucleotides e.g., DNA or RNA molecules or fragments thereof, PCR products, sequencing reaction products, and the like, are separated by size and/or charge in a sieving medium, e.g., a sieving medium as described above.
  • the separation is typically an electrophoretic separation.
  • the separated products are detected, often as they pass a detector (nucleic acids are typically labeled with radioactive nucleotides or fluorophores; accordingly appropriate detectors include spectrophotometers, fluorescent detectors, microscopes (e.g., for fluorescent microscopy) and scintillation counting devices).
  • a sequencing reaction e.g., a chain termination method of sequencing
  • detection of size separated products is used to compile sequence information for the region being sequenced.
  • Electrophoretic separation is the separation of substances achieved by applying an electric field to samples in a solution or gel, e.g., a polymer solution. In its simplest form, it depends on the different velocities with which the substances or components move in the field. The velocities depend, e.g., on the charge and size of the substances.
  • the polynucleotides are separated in a microscale separation channel or capillary.
  • the separation channels or regions typically comprise a separation matrix, e.g., a polymerized sieving medium as discussed above.
  • the sieving medium optionally comprises a gel or solution.
  • the concentration of the polymer in the separation gel or solution is less than about 0.5%.
  • the concentration of the sieving medium is less than about 0.4% and more typically about 0.35% or less.
  • the polymer concentration can be greater than 0.5%, e.g., 0.55%, 0.6% or higher. See e.g., U.S. Ser. No. 09/093,832 by Burd Mehta et al.
  • the channel such as channel 103 in FIG. 1, is a polyacrylamide gel filled channel or a polydimethylacrylamide/co-acrylic acid polymer filled channel on which the mixture of components is electrophoretically separated based on charge/mass ratio or molecular weight.
  • Polyacrylamide used as a separation matrix in a microfluidic channel is optionally cross-linked or non-cross-linked.
  • it is linear polyacrylamide, i.e., polydimethylacrylamide, polydimethylacrylamide/co-acrylic acid, or the like.
  • Other polymers include cellulose, agarose, Genescan polymers, and the like.
  • a detector is optionally positioned so that it detects the polynucleotides, e.g., polynucleotides that are stained in the gel with a fluorescent nucleic acid stain. If the components are detected as they exit the separation region, the components are optionally identified by their retention times. The retention time of the oligonucleotides as they are electrophoresed through the sieving medium is used, e.g., in combination with markers to measure the molecular weight of and identify the polynucleotides.
  • FIG. 3 demonstrates baseline separation of polynucleotides achieved using the low polymer concentration sieving mediums of the present invention, e.g., a sieving medium comprising 0.35% polymer.
  • PCR can be performed in the same sieving matrix used to separate nucleic acids.
  • PCR is optionally performed in the presence of a low polymer sieving matrix, and the products of the PCR reaction are separable in the same sieving matrix, e.g., in a microfluidic channel.
  • the invention provides new methods of performing PCR.
  • components of a PCR reaction mixture i.e., the molecules which participate in a PCR reaction, such as PCR extension primers, nucleotide triphosphates, thermostable enzymes, ions and buffer components such as Mg ++ , template DNAs, etc.
  • a sieving medium comprising less than about 0.5% polymer to provide a PCR sieving medium.
  • the sieving medium comprises less than about 0.4% polymer.
  • the sieving medium comprises about 0.35% polymer or less.
  • the sieving medium can comprise more than 0.5% polymer.
  • the resulting mixture e.g., the PCR sieving medium
  • Sieving mediums of use in performing PCR e.g., with nucleic acid separation of the products, are described above.
  • the most common form of in vitro amplification i.e., PCR amplification, generally involves the use of one strand of the target nucleic acid sequence, e.g., the sequence to be amplified, as a template for producing a large number of complements to that sequence.
  • PCR amplification generally involves the use of one strand of the target nucleic acid sequence, e.g., the sequence to be amplified, as a template for producing a large number of complements to that sequence.
  • two primer sequences complementary to different ends of a segment of the complementary strands of the target sequence hybridize with their respective strands of the target sequence, and in the presence of polymerase enzymes and nucleoside triphosphates, the primers are extended along the target sequence through the action of the polymerase enzyme (in asymmetric PCR protocols, a single primer is used).
  • PCR amplification typically involves repeated cycles of denaturation, hybridization and extension reactions to produce sufficient amounts of the target nucleic acid, all of which are carried out at different temperatures.
  • melting of the strands, or heat denaturation involves temperatures ranging from about 90° C. to 100° C. for times ranging from seconds to minutes.
  • the temperature is then cycled down, e.g., to between about 40° C. and 65° C. for annealing of primers, and then cycled up to between about 70° C. and 85° C. for extension of the primers along the target strand. This process if referred to herein as “thermocycling.”
  • RNA polymerase mediated techniques e.g., NASBA
  • PCR polymerase chain reaction
  • LCR ligase chain reaction
  • NASBA RNA polymerase mediated techniques
  • the PCR reactants are mixed with a sieving medium comprising a low polymer concentration, e.g., 0.5% or less.
  • the products are then directly separated, e.g., in a capillary, using the same sieving medium.
  • the components of the PCR reaction mixture e.g., a polymerase, nucleotides, and the like
  • a sieving medium e.g., with a low polymer concentration
  • the apparatus optionally includes one or more additional channels crossing the microfluidic channel and optionally includes fluid (or joule heating) means such as an electrokinetic controller for thermocycling and fluid direction systems, e.g., electrokinetic controllers and/or pressure sources such as vacuum sources, for flowing materials and reagents through the channels.
  • the PCR products are typically electrophoresed through the channels in the same sieving medium used to achieve product separation. Detection regions in the channels and corresponding detectors are also used, e.g., to detect the separated products.
  • Microfluidic devices comprising a PCR compatible nucleic acid sieving medium
  • the sieving medium of the invention is typically used in a microfluidic device and the separation and PCR methods described above are preferably performed in a microfluidic device.
  • the sieving medium is typically polymerized in a microscale channel of a microfluidic device, e.g., after the PCR reaction.
  • dynamic sieving mediums such as Genescan polymers, are used that do not require polymerization in the channel.
  • PCR and separation of the products are both optionally performed in a sieving medium of the present invention in the channels of a microfluidic device.
  • microfluidic devices are optionally adapted for use in the present invention, e.g., by designing and configuring the channels as discussed below. These devices are described in various PCT applications and issued U.S. Patents by the inventors and their coworkers, including U.S. Pat. Nos. 5,699,157 (J. Wallace Parce) issued Dec. 16, 1997, 5,779,868 (J. Wallace Parce et al.) issued Jul. 14, 1998, 5,800,690 (Calvin Y. H. Chow et al.) issued Sep. 1, 1998, 5,842,787 (Anne R. Kopf-Sill et al.) issued Dec. 1, 1998, 5,852,495 (J. Wallace Parce) issued Dec.
  • One aspect of the invention is the placement of the sieving medium in selected channels or channel regions of a microfluidic substrate.
  • These materials or precursors of the materials, e.g., monomers polymerized in the device as discussed above) are loaded into microfluidic components by electrokinesis, by pressurized pumping, by centrifugal force, or capillary flow.
  • the present invention provides methods of DNA separation and PCR that are both compatible with the sieving mediums of the invention. Therefore, the sieving medium is typically loaded throughout the entire device. However if other assays are steps are desired, e.g., DNA sequencing reactions, certain channels are optionally filled with reagents for the desired assay or left empty.
  • a sieving medium e.g., in an unpolymerized solution that, upon polymerization, forms a sieving matrix.
  • Elements of the microfluidic device such as microfluidic channels are filled with the sieving medium by forcing the fluid into the channel under pressure, or by moving the fluid into the channel electrokinetically.
  • the first fluid polymerizes upon exposure to light (i.e., the fluid comprises a “photopolymerizable” polymer). The fluid is then selectively exposed to light (e.g., using photomasking techniques) in those regions where a polymerized gel is desired. Unpolymerized fluid is then optionally washed out of the unselected regions of the microfluidic device, or into a waste reservoir using electrokinetic flow or pressure.
  • monomer is pumped, e.g., in aqueous buffer, into a channel or channel region using electroosmotic flow, or using a pressure gradient.
  • electroosmotic flow e.g., aqueous buffer
  • pressure gradient e.g., a pressure gradient
  • a sieving matrix is deposited throughout a channel or channels of a microfluidic device in a form which is subject to electroosmosis (i.e., the matrix moves electrokinetically in the channel).
  • a sieving medium is loaded into multiple channels of a microfluidic device, e.g., under pressure, and polymerized in place.
  • Selective components which solubilize the polymerized gel are then loaded (e.g., electrokinetically or under pressure) into channel regions where polymerized product is not desired, i.e., channels in which other assays are to be performed.
  • the selected components dissolve the polymerized gel.
  • Example of solubilization compounds include acids, bases and other chemicals.
  • at least two compounds are used to dissolve polymerized products, where both products need to be present to dissolve the polymer. This provides for fine control of dissolution, e.g., where each chemical is under separate electrokinetic control.
  • DTT N,N′-bis(acrylol)cystamine or (1,2-dihydroxyethylene-bis-acrylamide) [DHEBA] and sodium periodiate or calcium alginate+EDTA or TCEP-HCL and N,N′-bis(acryloyl)cystamine.
  • DHEBA (1,2-dihydroxyethylene-bis-acrylamide)
  • sodium periodiate or calcium alginate+EDTA or TCEP-HCL and N,N′-bis(acryloyl)cystamine A variety of such materials are known.
  • the sieving medium of the invention is particularly useful for performing experimental or diagnostic procedures which combine nucleic acid amplification and product separatory aspects. For example, PCR is performed in a microfluidic channel comprising a sieving medium as described herein, followed by separation in the same sieving medium, e.g., in the same or in a different channel region.
  • PCR or other thermal reaction reagents such as thermostable polymerase, DNA template, primers, nucleotides and buffers are mixed, e.g., with a sieving medium, in a microchannel or chamber, with the entire microfluidic substrate (e.g., a LABCHIPTM from Caliper Technologies) being subject to repeated cycles of heating and cooling, e.g., on a thermocycler or by switching between a hot plate and a heat sink.
  • a sieving medium e.g., a LABCHIPTM from Caliper Technologies
  • variations in channel thickness and/or voltage are used selectively to heat selected regions of a channel which contain a PCR reaction.
  • PCR amplification is particularly well suited to this use in the apparatus, methods and systems of the invention.
  • Thermocycling amplification methods including PCR and LCR, are conveniently performed in microscale devices, making iterative fluidic operations involving PCR well suited to use in methods and devices of the present invention (see also, U.S. Pat. Nos. 5,498,392 and 5,587,128 to Willingham et al.).
  • generation of amplicons such as sequencing templates using PCR, or direct sequencing of nucleic acids by PCR (e.g., using nuclease digestion as described supra) is performed with the integrated systems and devices of the invention.
  • thermocycling in microscale devices including thermocycling by joule heating is described in WO 99/12016, entitled “ELECTRICAL CURRENT FOR CONTROLLING FLUID PARAMETERS IN MICROCHANNELS” published Mar. 11, 1999 by Calvin Chow, Anne R. Kopf-Sill and J. Wallace Parce; in 08/977,528, filed Nov. 25, 1997; in WO 98/45481, entitled “CLOSED-LOOP BIOCHEMICAL ANALYZERS,” published Oct. 15, 1998; and in 09/287,069, entitled INEFFICIENT FAST PCR, filed Apr. 6, 1999 by Kopf-Sill.
  • energy is provided to heat fluids, e.g., samples, analytes, buffers and reagents, in desired locations of the substrates in an efficient manner by application of electric current to fluids in microchannels.
  • the present invention optionally uses power sources that pass electrical current through a first channel region for heating purposes, as well as for material transport.
  • fluid passes through a channel of a desired cross-section (e.g., diameter) to enhance thermal transfer of energy from the current to the fluid.
  • the channels can be formed on almost any type of substrate material such as, for example, amorphous materials (e.g., glass, plastic, silicon), composites, multi-layered materials, combinations thereof, and the like.
  • POWER power dissipated in fluid
  • I electric current passing through fluid
  • R electric resistance of fluid
  • the above equation provides a relationship between power dissipated (“POWER”) to current (“I”) and resistance (“R”).
  • POWER power dissipated
  • I current
  • R resistance
  • a portion of the power goes into kinetic energy of moving the fluid through the channel.
  • a selected portion of the power to controllably heat fluid in a channel or selected channel regions.
  • a channel region suitable for heating is often narrower or smaller in cross-section than other channel regions in the channel structure, as a smaller cross-section provides higher resistance in the fluid, which increases the temperature of the fluid as electric current passes through.
  • the electric current is increased across the length of the channel by increased voltage, which also increases the amount of power dissipated into the fluid to correspondingly increase fluid temperature.
  • a power supply applies voltage and/or current in one of many ways.
  • a power supply can apply direct current (i.e., DC) or alternating current (AC), which passes through the channel and into a channel region which is smaller in cross-section, thereby heating fluid in the region.
  • DC direct current
  • AC alternating current
  • This current is selectively adjusted in magnitude to complement any voltage or electric field that is applied to move fluid in and out of the region.
  • AC current, voltage, and/or frequency can be adjusted, for example, to heat the fluid without substantially moving the fluid.
  • a power supply can apply a pulse or impulse of current and/or voltage, which passes through the channel and into a channel region to heat fluid in the region.
  • This pulse is selectively adjusted to complement any voltage or electric field that is applied to move fluid in and out of the region.
  • Pulse width, shape, and/or intensity can be adjusted, for example, to heat the fluid substantially without moving the fluid or to heat the fluid while moving the fluid.
  • the power supply can apply any combination of DC, AC, and pulse, depending upon the application. In practice, direct application of electric current to fluids in the microchannels of the invention results in extremely rapid and easily controlled changes in temperature.
  • a controller or computer such as a personal computer monitors the temperature of the fluid in the region of the channel where the fluid is heated.
  • the controller or computer receives current and voltage information from, for example, the power supply and identifies or detects temperature of fluid in the region of the channel.
  • the controller or computer adjusts voltage and/or current to meet the desired fluid temperature.
  • the controller or computer also can be set to be “current controlled” or “voltage controlled” or “power controlled” depending upon the application.
  • the region which is heated can be a “coil” which is optionally in a planar arrangement. Transfer of heat from the coil to a reaction channel through a substrate material is used to heat the reaction channel. Alternatively, the coil itself is optionally the reaction channel.
  • a voltage is applied between regions of the coil to direct current through the fluid for heating purposes.
  • a power supply provides a voltage differential between regions of the coil.
  • Current flows between the regions and traverses a plurality of coils or coil loops (which can be planar), which are defined by a substrate. Shape and size of the coils can influence an ability of current to heat the fluid in the coil. As current traverses through the fluid, energy is transferred to the fluid for heating purposes.
  • Cooling coils can also be used. As a cooling coil, a fluid traverses from region to region in the coil, which can be placed to permit heat transfer through a substrate from a sample.
  • the cooling fluid can be a variety of substances including liquids and gases. As merely an example, the cooling fluid includes aqueous solutions, liquid or gaseous nitrogen, and others. The cooling fluid can be moved between regions using any of the techniques described herein, and others. Further details are found in Chow et al., supra.
  • Joule heating in microchannels is an example of how benchtop methods can be dramatically improved in the formats provided herein. PCR takes hours to perform currently, primarily because it takes a long time for conventional heating blocks to oscillate between temperatures. In addition, reagent cost is an obstacle to massive experimentation. Both these parameters are altered by orders of magnitude in the LabChipTM format.
  • PCR reaction conditions are controlled as a function of channel geometry.
  • Microfabrication methods permit the manufacture of channels that have precise variations in cross sectional area. Since the channel resistance is inversely proportional to the cross sectional area, the temperature varies with the width and depth of the channel for a given flow of current. As fluid moves through a structure of varying cross sectional area, its temperature will change, depending on the dimensions of the channel at any given point. The amount of time it experiences a given temperature will be determined by the velocity of the fluid flow, and the length of channel with those dimensions. This concept is illustrated in FIG. 2. Nucleic acids of typical lengths have a low diffusion coefficient (about 10 ⁇ 7 cm/sec 2 ).
  • amplification reactions are performed concurrently in series using biased alternating current to heat the fluid inside the channel and move material through it.
  • the time for each step of the reaction is controlled by determining the speed of movement and the length of channel having particular widths. Flow can be reversed to allow a single small channel region to be used for many separate amplifications.
  • Sample 215 is in narrow channel region 220 ; in operation, this region is heated to, e.g., 95° C. (hot enough to denature nucleic acids present in sample 215 , but cool enough that thermostable reagents such as Taq DNA polymerase are relatively stable due to the relative size of region 220 and the applied current.
  • wide channel region 230 is heated, e.g., to 60° C. (cool enough for binding of primers in sample 225 and initiation of polymerase extension), due to the relative size of region 230 and the applied current.
  • intermediate channel region 235 is heated, e.g., to 72° C.
  • This process can be concurrently carried out with a plurality of additional channel regions such as narrow region 245 , wide region 250 and intermediate region 255 , with samples 260 , 265 and 270 .
  • direct detection of amplified products can be employed.
  • differentially labeled competitive probe hybridization is used for single nucleotide discrimination.
  • molecular beacons or single nucleotide polymerase extension can be employed.
  • Homogeneous detection by fluorescence polarization spectroscopy can also be utilized (fluorescence polarization has been used to distinguish between labeled small molecules free in solution or bound to protein receptors).
  • the present invention provides the ability to integrate complex functions such as PCR and nucleic acid separation in a single format, e.g., in a microfluidic device.
  • PCR and nucleic acid separations are optionally performed in the same sieving medium, therefore making it possible to perform both functions in a single channel of a microfluidic device.
  • FIG. 1 provides a schematic of an example device.
  • Device 100 is optionally filled with a sieving medium as described above, e.g., a sieving gel.
  • the sieving medium provides a continuous fluid phase throughout the device, such that PCR is optionally carried out by joule heating in one channel, e.g., channel 101 , and product separation in another channel, e.g., channel 103 .
  • the entire device is thermocycled to perform PCR. PCR is thereby carried out in the sieving medium.
  • PCR reagents and a target nucleic acid are added to the sieving medium if not already incorporated therein, e.g., into channel 101 .
  • Cross channel 101 is optionally a PCR channel as described herein and shown in FIG. 2.
  • the loaded device is typically placed on a thermocycler (MJ Research) and the temperature is typically cycled to amplify the target nucleic acid.
  • the chip is typically placed on a microscope detection station and the product is electrokinetically injected into separation channel 103 .
  • voltages are applied at wells 107 and 109 to electrokinetically separate the product nucleic acids.
  • An example spectrum showing separated nucleic acid peaks is provided in FIG. 3.
  • PCR reaction product is selected for further manipulations such as cloning, sequencing or the like, all of which are optionally performed in the same device (see also, U.S. Ser. No. 60/068,311, entitled “Closed Loop Biochemical Analyzer” by Knapp, filed Dec. 19, 1997 and “Closed Loop Biochemical Analyzers” by Knapp et al. U.S. Ser. No. 09/054,962, filed Apr. 3, 1998).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Sieving mediums comprising less than about 0.5% polymer, less than about 0.4% polymer, and 0.35% polymer or less are used to perform nucleic acid separations and PCR. The low polymer concentration does not inhibit PCR reactions and is sufficient for performing nucleic acids separations. Microfluidic devices are used to perform nucleic acids separations and PCR reactions in the sieving mediums described.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • Pursuant to 35 U.S.C. § 119(e) and any other applicable statute or rule, the present application claims benefit of and priority to U.S. Ser. No. 60/190,773, entitled “PCR COMPATIBLE NUCLEIC ACID SIEVING MEDIUM,” filed Mar. 20, 2000 by Burd Mehta.[0001]
  • BACKGROUND OF THE INVENTION
  • Manipulating fluidic reagents and assessing the results of reagent interactions are central to chemical and biological science. Manipulations include mixing fluidic reagents, assaying products resulting from such mixtures, separation or purification of products and reagents, and the like. A single experiment may involve hundreds of fluidic manipulations, product separations, recording processes and the like, each of which involve different types of laboratory equipment and conditions. [0002]
  • One particularly labor intensive biochemical series of laboratory fluidic manipulations is nucleic acid synthesis and analysis. A variety of in vitro amplifications methods for biochemical synthesis of nucleic acids are available, such as the polymerase chain reaction (PCR). See, Mullis et al., (1987) U.S. Pat. No. 4,683,202 and PCR protocols: A Guide to Methods and Applications (Innis et al. eds., Academic Press Inc. San Diego Calif. (1990). PCR methods typically require the use of specialized machinery for performing thermocycling reactions for DNA synthesis followed by the use of special machinery for the electrophoretic analysis of synthesized nucleic acids. [0003]
  • Various strategies have been used to increase laboratory throughput. For example, microscale devices for high throughput mixing and assaying small fluid volumes have been developed. See, e.g., Parce et al., U.S. Pat. No. 5,942,443, “High Throughput Screening Assay Systems in Microscale Devices,” which provides pioneering technology related to microscale devices. In particular, U.S. Ser. No. 09/093,832 by Burd Mehta et al., “Microfluidic Matrix Localization Apparatus and Methods,” provides methods of performing PCR and nucleic acid separations in the same microfluidic device. [0004]
  • Improved methods for performing PCR and nucleic acid separations including improved sieving mediums are desirable, particularly those which take advantage of high-throughput, low cost microfluidic systems. The present invention provides these and other features by providing nucleic acid sieving mediums, methods of performing PCR and nucleic acid separations along with high throughput microscale systems and many other features that will be apparent upon complete review of the following disclosure. [0005]
  • SUMMARY OF THE INVENTION
  • The present invention provides nucleic acid sieving mediums, microfluidic devices, and methods for performing nucleic acid separations and PCR. The sieving mediums provided are compatible with both nucleic acid separations and PCR because they provide baseline nucleic acid separation and do not inhibit PCR. [0006]
  • In one aspect, a microfluidic device for performing both PCR and nucleic acid separations is provided. The device comprises at least one microscale channel and a sieving medium. The sieving medium is disposed within the at least one microscale channel and comprises a polymer solution, which polymer solution comprises less than about 0.5% polymer, less than about 0.4% polymer, or about 0.35% polymer or less. [0007]
  • Typical polymers include acrylamide, such as linear acrylamide, polyacrylamide, polydimethylacrylamide, polydimethylacrylamide/coacrylic acid, and the like. Other polymers include, but are not limited to, agarose, methyl cellulose, polyethylene oxide, hydroxycellulose, hydroxy ethyl cellulose, and the like. [0008]
  • The devices also optionally comprise one or more proteins, nucleic acids, PCR reaction components, or PCR products disposed within the at least one microfluidic channel. PCR reaction components include, but are not limited to, a polymerase, e.g., a thermostable DNA polymerase, a plurality of nucleotides, a nucleic acid template, a primer which hybridizes to the nucleic acid template, and Mg[0009] ++.
  • In a second aspect, methods of separating polynucleotides are provided. In one embodiment, the method comprises providing two or more polynucleotides and a sieving medium. The polynucleotides typically comprise one or more PCR products, RNA, or DNA. The sieving medium typically comprises a polymer solution as described above. The two or more polynucleotides migrate through the sieving medium, thereby separating the two or more polynucleotides. [0010]
  • In another embodiment, the sieving medium is introduced into a microfluidic channel and the two or more polynucleotides migrate through the sieving medium in the microfluidic channel. For example, the two or more polynucleotides are optionally separated by electrophoresis in the sieving medium. [0011]
  • In a third aspect, methods of performing PCR and separating one or more PCR products are provided. The methods comprise mixing one or more PCR reaction component as described above with a sieving medium to provide a PCR sieving medium, wherein the sieving medium comprises a polymer solution as described above. The PCR sieving medium is then thermocycled to produce one or more PCR products, which are separated by flowing in the sieving medium. [0012]
  • In another embodiment, PCR is performed in a microfluidic device by mixing the PCR reaction components with the sieving medium in a microfluidic channel. The one or more PCR products are separated, e.g., electrophoretically, by flowing the one or more PCR products through the sieving medium in the microfluidic channel. [0013]
  • In a fourth aspect, nucleic acid sieving mediums are provided. The sieving mediums comprise one or more polynucleotides, such as DNA, RNA, PCR products, or the like, one or more PCR reagents as described above, and a polymer solution as described above.[0014]
  • BRIEF DESCRIPTION OF THE DRAWING
  • FIG. 1 is a schematic drawing of a microfluidic device for performing PCR and nucleic acid separations. [0015]
  • FIG. 2 is a schematic drawing of a microchannel for joule heating. [0016]
  • FIG. 3 is a graph providing nucleic acid separation data obtained in a sieving medium comprising 0.35% polymer.[0017]
  • DETAILED DISCUSSION OF THE INVENTION
  • DNA separations are normally performed in sieving mediums that have a certain concentration of sieving medium to achieve separation of various sizes of DNA fragments. The concentration of polymers used in sieving media typically inhibits the polymerase chain reaction (PCR), thereby preventing the two assays from being carried out in one medium. The present invention provides a mixture compatible with PCR that also serves as a DNA separation medium. The sieving mediums of the present invention comprise lower concentrations of polymer than are normally used to achieve DNA separation. The lower concentrations of polymer do not inhibit PCR and still provide separation of polynucleotides. [0018]
  • A typical sieving polymer concentration used in DNA separations is about 3%, e.g., 3% acrylamide. This concentration is known to inhibit polymerase chain reactions (PCR). However, lower levels of the same polymer are not inhibitory. The present invention provides a PCR compatible mixture with a low amount of polymer used to suppress electroosmotic flow in the channels of a microfluidic device. The concentration of polymer provided in the present invention is typically less than about 0.5%, more typically less than about 0.4% and preferably about 0.35% or less. Since this is below the usual threshold of sieving, the polymer here was initially used as an agent to eliminate bulk movement of the fluid by acting as a dynamic coating for the channel walls. [0019]
  • However, the present sieving medium also provided nucleic acid separations in the same low polymer medium in which PCR was performed. While, the exact mechanism of DNA sieving is not known, one advantage of the present medium is to provide a single fluid compatible with PCR and nucleic acid separations. Thus, the present invention provides, with a relatively simple loading or fabrication procedure, multi-step assays, e.g., PCR and subsequent product separation, using the present sieving medium. [0020]
  • The present invention provides a nucleic acid sieving medium compatible with nucleic acid separations and PCR as well as devices for performing nucleic acid separations and PCR, e.g., devices comprising a sieving medium with a low polymer concentration. Methods of separating nucleic acids and performing PCR using low concentration sieving mediums are also provided. [0021]
  • I. PCR Compatible Sieving Mediums [0022]
  • A nucleic acid sieving medium that is compatible with PCR and nucleic acid separations is provided. The sieving medium comprises a low concentration of polymer, which low concentration does not inhibit PCR. Typically DNA is separated in sieving mediums with higher polymer concentrations than those provided herein. However, nucleic acids are optionally separated using the lower polymer concentrations provided herein thereby providing methods for performing nucleic acid separation and PCR in the same medium. [0023]
  • The sieving medium typically comprises one or more polynucleotides, one or more PCR reagents, and a polymer solution, which polymer solution comprises less than about 0.5% polymer, less than about 0.4% polymer, or about 0.35% polymer or less. The polymer solution is thereby used to provide PCR and nucleic acid separations in the same matrix. In some embodiments, the polymer solution is eliminated and optionally replaced with an electroosmotic flow suppressor. [0024]
  • The one or more PCR reaction components comprise one or more of: a thermostable polymerase, a thermostable DNA polymerase, a plurality of nucleotides, a nucleic acid template, a primer which hybridizes to the nucleic acid template, Mg[0025] ++, and the like. The one or more polynucleotides typically comprise DNA, RNA, or PCR products.
  • Typical polymer solutions of the invention comprise low concentrations of one or more of the following: acrylamide, agarose, methyl cellulose, polyethylene oxide, hydroxycellulose, hydroxy ethyl cellulose, or the like. Combinations of any of these polymers are also optionally used. Various types of acrylamide are used, including, but not limited to, linear acrylamide, polyacrylamide, polydimethylacrylamide, polydimethylacrylamide/coacrylic acid, or the like. [0026]
  • A wide variety of alternative sieving mediums are available, and are optionally used in methods of the invention, e.g., at low concentrations to provide a medium compatible with both PCR and nucleic acid separations. For example, a variety of sieving matrixes and the like are available from Supelco, Inc. (Bellefonte, Pa.; see, 1997 Suppleco catalogue). Common matrixes which are useful in the present invention include those generally used in low pressure liquid chromatography, gel electrophoresis and other liquid phase separations; matrix materials designed primarily for non-liquid phase chromatography are also useful in certain contexts, as the materials often retain separatory characteristics when suspended in fluids. For a discussion of electrophoresis see, e.g., Weiss (1995) [0027] Ion Chromatography VCH Publishers Inc.; Baker (1995) Capillary Electrophoresis John Wiley and Sons; Kuhn (1993) Capillary Electrophoresis: Principles and Practice Springer Verlag; Righetti (1996) Capillary Electrophoresis in Analytical Biotechnology CRC Press; Hill (1992) Detectors for Capillary Chromatography John Wiley and Sons; Gel Filtration: Principles and Methods (5th Edition) Pharmacia; Gooding and Regnier (1990) HPLC of Biological Macromolecules: Methods and Applications (Chrom. Sci. Series, volume 51) Marcel Dekker and Scott (1995) Techniques and Practices of Chromatography Marcel Dekker, Inc.
  • Alternate separation matrix media include, but are not limited to, low pressure liquid chromatography media include, e.g., non-ionic macroreticular and macroporous resins which adsorb and release components based upon hydrophilic or hydrophobic interactions such as Amberchrom resins (highly cross-linked styrene/divinylbenzene copolymers suitable for separation of peptides, proteins, nucleic acids, antibiotics, phytopharmacologicals, and vitamins); the related Amberlite XAD series resins (polyaromatics and acrylic esters) and amberchroms (polyaromatic and polymethacrylates) (manufactured by Rohm and Haas, available through Suppleco); Diaion (polyaromatic or polymethacrylic beads); Dowex (polyaromatics or substituted hydrophilic functionalized polyaromatics) (manufactured by Dow Chemical, available through Suppleco); Duolite (phenol-formaldehyde with methanolic functionality), MCI GEL sephabeads, supelite DAX-8 (acrylic ester) and Supplepak (polyaromatic) (all of the preceding materials are available from Suppleco). For a description of uses for Amberlite and Duolite resins, see, [0028] Amberlite/Duolite Anion Exchange Resins (Avaliable from Suppleco, Cat No. T412141). Gel filtration chromatography matrixes are also suitable, including sephacryl, sephadex, sepharose, superdex, superose, toyopearl, agarose, cellulose, dextrans, mixed bead resins, polystyrene, nuclear resins, DEAE cellulose, Benzyl DEA cellulose, TEAE cellulose, and the like (Suppleco).
  • Other electrophoresis media include silica gels such as Davisil Silica, E. Merck Silica Gel, Sigma-Aldrich Silica Gel (all available from Suppleco) in addition to a wide range of silica gels available for various purposes as described in the Aldrich catalogue/handbook (Aldrich Chemical Company (Milwaukee, Wis.)). Preferred gel materials include agarose based gels, various forms of acrylamide based gels, Genescan polymers (reagents available from, e.g., Suppleco, SIGMA, Aldrich, SIGMA-Aldrich and many other sources), colloidial solutions such as protein colloids (gelatins) and hydrated starches. Various forms of gels are discussed further below. [0029]
  • A variety of affinity media for purification and separation of molecular components are also available, including a variety of modified silica gels available from SIGMA, Aldrich and SIGMA-Aldrich, as well as Suppleco, such as acrylic beads, agarose beads, cellulose, sepharose, sepharose CL, toyopearl, or the like chemically linked to an affinity ligand such as a biological molecule. A wide variety of activated matrixes, amino acid resins, avidin and biotin resins, carbohydrate resins, dye resins, glutathione resins, hydrophobic resins, immunochemical resins, lectin resins, nucleotide/coenzyme resins, nucleic acid resins, and specialty resins are available, e.g., from Suppleco, SIGMA, Aldrich or the like. See also, Hermanson et al. (1992) [0030] Immobilized Affinity Ligand Techniques Academic Press and optionally used in the channels of the invention.
  • Other media commonly used in chromatography are also adaptable to the present invention, including activated aluminas, carbopacks, carbosieves, carbowaxes, chromosils, DEGS, Dexsil, Durapak, Molecular Sieve, OV phases, pourous silica, chromosorb series packs, HayeSep series, Porapak series, SE-30, Silica Gel, SP-1000, SP-1200, SP-2100, SP-2250, SP-2300, SP2401, Tenax, TCEP, supelcosil LC-18-S and LC-18-T, Methacrylate/DVBm, polyvinylalcohols, napthylureas, non-polar methyl silicone, methylpolysiloxane, poly (ethylene glycol) biscyanopropyl polysiloxane and the like. [0031]
  • Other types of separation matrices are also optionally used and discussed in U.S. patent application Ser. No. 09/093,832 filed Jun., 8, 1998, entitled “Microfluidic Matrix Localizations Apparatus and Methods,” by Mehta and Kopf-Sill. For a review of chromatography techniques and media, see, e.g., Affinity Chromatography—A Practical Approach, Dean et al., (Eds.) IRL Press, Oxford (1985); and, Chromatographic Methods, 5[0032] th Edition, Braithwaite et al., (1996).
  • Many of the materials used to provide the sieving mediums of the invention are supplied in a liquid or fluidic phase and then polymerized to provide a sieving matrix. In one embodiment, the fluid polymerizes upon exposure to light (i.e., the fluid comprises a “photopolymerizable” polymer). The fluid is then selectively exposed to light (e.g., using photomasking techniques) in those regions where a polymerized gel is desired. Unpolymerized fluid is then optionally washed out of the unselected regions of the microfluidic device, or into a waste reservoir using electrokinetic flow or pressure. [0033]
  • A wide variety of free-radical polymerizable monomers photopolymerize to form gels, or can be made photopolymerizeable by the addition of, e.g., energy transfer dyes. For example, free-radical polymerizable monomers can be selected from acrylate, methacrylate and vinyl ester functionalized materials. They can be monomers and/or oligomers such as (meth)acrylates (meth)acrylamides, acrylamides, vinyl pyrrolidone and azalactones. Such monomers include mono-, di-, or poly-acrylates and methacrylates such as methyl acrylate, methyl methacrylate, ethyl acrylate, isopropyl methacrylate, isooctyl acrylate, isobornyl acrylate, isobornyl methacrylate, acrylic acid, n-hexyl acrylate, stearyl acrylate, allyl acrylate, glycerol diacrylate, glycerol triacrylate, ethylene glycol diacrylate, diethyleneglycol diacrylate, triethyleneglycol dimethacrylate, 1,6-hexanediol diacrylate, 1,3-propanediol diacrylate, 1,3-propanediol dimethacrylate, trimethanol triacrylate, 1,2,4-butanetriol trimethylacrylate, 1,4-cyclohexanediol diacrylate, pentaerythritol triacrylate, pentaerythritol tetraacrylate, pentaerythritol tetramethacrylate, sorbitol hexacrylate, bis[1-(2-acryloxy)]-p-ethoxyphenyl-dimethylmethane, bis[1-(3-acryloxy-2-hydroxy)]-propoxyphenyl dimethylmethane, tris-hydroxyethyl isocyanurate trimethacrylate; the bis-acrylates and bis-methacrylates of polyethylene glycols of molecular weight 200-500, copolymerizable mixtures of acrylated monomers, acrylated oligomers, PEG diacrylates, etc. Strongly polar monomers such as acrylic acid, acrylamide, itaconic acid, hydroxyalkyl acrylates, or substituted acrylamides or moderately polar monomers such as N-vinyl-2-pyrrolidone, N-vinyl caprolactam, and acrylonitrile are also useful. [0034]
  • Proteins such as gelatin, collagen, elastin, zein, and albumin, whether produced from natural or recombinant sources, which are made by free-radical polymerization by the addition of carbon-carbon double or triple bond-containing moieties, including acrylate, diacrylate, methacrylate, ethacrylate, 2-phenyl acrylate, 2-chloro acrylate, 2-bromo acrylate, itaconate, oliogoacrylate, dimethacrylate, oligomethacrylate, acrylamide, methacrylamide, styrene groups, and other biologically acceptable photopolymerizable groups, can also be used, e.g., in low concentration, to form sieving matrixes. [0035]
  • Dye-sensitized polymerization is well known in the chemical literature. For example, light from an argon ion laser (514 nm), in the presence of an xanthin dye and an electron donor, such as triethanolamine, to catalyze initiation, serves to induce a free radical polymerization of acrylic groups in a reaction mixture (Neckers, et al., (1989) [0036] Polym. Materials Sci. Eng., 60:15; Fouassier, et al., (1991) Makromol. Chem., 192:245-260). After absorbing laser light, the dye is excited to a triplet state. The triplet state reacts with a tertiary amine such as the triethanolamine, producing a free radical which initiates a polymerization reaction. Polymerization is extremely rapid and is dependent on the functionality of the composition, its concentration, light intensity, and the concentration of dye and, e.g., amine.
  • Dyes are also optionally used which absorb light having a frequency between 320 nm and 900 nm, form free radicals, are water soluble, etc. There are a large number of photosensitive dyes that are optionally used to optically initiate polymerization, such as ethyl eosin, eosin Y, fluorescein, 2,2-dimethoxy-2-phenyl acetophenone, 2-methoxy,2-phenylacetophenone, camphorquinone, rose bengal, methylene blue, erythrosin, phloxime, thionine, riboflavin, methylene green, acridine orange, xanthine dye, and thioxanthine dyes. [0037]
  • Cocatalysts useful with photoinitiating dyes are typically nitrogen based compounds capable of stimulating a free radical reaction. Primary, secondary, tertiary or quaternary amines are suitable cocatalysts, as are nitrogen atoms containing electron-rich molecules. Cocatalysts include triethanolamine, triethylamine, ethanolamine, N-methyl diethanolamine, N,N-dimethyl benzylamine, dibenzyl amine, N-benzyl ethanolamine, N-isopropyl benzylamine, tetramethyl ethylenediamine, potassium persulfate, tetramethyl ethylenediamine, lysine, ornithine, histidine and arginine. Examples of the dye/photoinitiator system include ethyl eosin with an amine, eosin Y with an amine, 2,2-dimethoxy-2-phenoxyacetophenone, 2-methoxy-2-phenoxyacetophenone, camphorquinone with an amine, and rose bengal with an amine. [0038]
  • In some cases, dye may absorb light and initiate polymerization, without any additional initiator such as an amine. In these cases, only the dye and a monomer need be present to initiate polymerization upon exposure to light. The generation of free radicals is terminated when the laser light is removed. Some photoinitiators, such as 2,2-dimethoxy-2-phenylacetophenone, do not require any auxiliary amine to induce photopolymerization; in these cases, the presence of dye, monomer, and an appropriate wavelength of light is sufficient for photopolymerization. [0039]
  • Preferred light sources include various lamps and lasers such as those which have a wavelength of about 320-800 nm. This light can be provided by any appropriate source able to generate the desired radiation, such as a mercury lamp, longwave UV lamp, He-Ne laser, an argon ion laser, etc. In a preferred embodiment, a UV source is used to polymerize a UV photopolymerizeable gel. Similarly, the light source used is typically selected based upon the chemistry which is to be affected by the source. [0040]
  • Similarly, a variety of gels or polymers are selectively polymerized by exposure to heat. As described herein, selective heat control using applied current is easily performed in the microfluidic apparatus of the invention, providing for simplified control of gel polymerization through thermal processes. Examples include initiation by thermal initiators, which form free radicals at moderate temperatures, such as benzoyl peroxide, with or without triethanolamine, potassium persulfate, with or without tetramethylethylenediamine, and ammonium persulfate with sodium bisulfite. [0041]
  • In another embodiment, the fluid is polymerized by selectively exposing it to an activator or cross-linker. For example, where the fluid is polyacrylamide, the activator/cross linker can be TEMED and/or APS. [0042]
  • The above polymers, e.g., in solution format, gel format, or the like, and typically polymerized as described above, are typically used in microfluidic devices to provide devices useful for both PCR and separation of nucleic acids. [0043]
  • II. Separating nucleic acids in a polymer sieving medium [0044]
  • A mixture of polynucleotides, e.g., DNA or RNA molecules or fragments thereof, PCR products, sequencing reaction products, and the like, are separated by size and/or charge in a sieving medium, e.g., a sieving medium as described above. For example, the separation is typically an electrophoretic separation. The separated products are detected, often as they pass a detector (nucleic acids are typically labeled with radioactive nucleotides or fluorophores; accordingly appropriate detectors include spectrophotometers, fluorescent detectors, microscopes (e.g., for fluorescent microscopy) and scintillation counting devices). If the separated components are the products of a sequencing reaction, e.g., a chain termination method of sequencing, detection of size separated products is used to compile sequence information for the region being sequenced. [0045]
  • Typically electrophoretic separation is used to separate the mixture of components in the sample. Electrophoretic separation is the separation of substances achieved by applying an electric field to samples in a solution or gel, e.g., a polymer solution. In its simplest form, it depends on the different velocities with which the substances or components move in the field. The velocities depend, e.g., on the charge and size of the substances. [0046]
  • In a preferred embodiment, the polynucleotides are separated in a microscale separation channel or capillary. The separation channels or regions typically comprise a separation matrix, e.g., a polymerized sieving medium as discussed above. When the sample is flowed through the separation matrix, the components are separated, e.g., based on physical or chemical properties, such as molecular weight or charge. In the present invention, the sieving medium optionally comprises a gel or solution. In the present invention, the concentration of the polymer in the separation gel or solution is less than about 0.5%. Typically the concentration of the sieving medium is less than about 0.4% and more typically about 0.35% or less. In other embodiments, the polymer concentration can be greater than 0.5%, e.g., 0.55%, 0.6% or higher. See e.g., U.S. Ser. No. 09/093,832 by Burd Mehta et al. [0047]
  • Preferably, the channel, such as [0048] channel 103 in FIG. 1, is a polyacrylamide gel filled channel or a polydimethylacrylamide/co-acrylic acid polymer filled channel on which the mixture of components is electrophoretically separated based on charge/mass ratio or molecular weight. Polyacrylamide used as a separation matrix in a microfluidic channel is optionally cross-linked or non-cross-linked. Preferably it is linear polyacrylamide, i.e., polydimethylacrylamide, polydimethylacrylamide/co-acrylic acid, or the like. Other polymers include cellulose, agarose, Genescan polymers, and the like.
  • For a review of electrophoretic separation techniques and polyacrylamide gels, see, e.g., The Encyclopedia of Molecular Biology, Kendrew (ed.) (1994); and, Gel Electrophoresis of Proteins: A Practical Approach, 2[0049] nd edition Hames and Rickwood (Eds.) IRL Press, Oxford England, (1990).
  • A detector is optionally positioned so that it detects the polynucleotides, e.g., polynucleotides that are stained in the gel with a fluorescent nucleic acid stain. If the components are detected as they exit the separation region, the components are optionally identified by their retention times. The retention time of the oligonucleotides as they are electrophoresed through the sieving medium is used, e.g., in combination with markers to measure the molecular weight of and identify the polynucleotides. [0050]
  • FIG. 3 demonstrates baseline separation of polynucleotides achieved using the low polymer concentration sieving mediums of the present invention, e.g., a sieving medium comprising 0.35% polymer. [0051]
  • III. Performing PCR in a sieving medium [0052]
  • One aspect of the present invention is the surprising discovery that PCR can be performed in the same sieving matrix used to separate nucleic acids. For example, PCR is optionally performed in the presence of a low polymer sieving matrix, and the products of the PCR reaction are separable in the same sieving matrix, e.g., in a microfluidic channel. [0053]
  • Accordingly, in one aspect, the invention provides new methods of performing PCR. In the methods, components of a PCR reaction mixture (i.e., the molecules which participate in a PCR reaction, such as PCR extension primers, nucleotide triphosphates, thermostable enzymes, ions and buffer components such as Mg[0054] ++, template DNAs, etc.) are mixed with a sieving medium comprising less than about 0.5% polymer to provide a PCR sieving medium. Typically, the sieving medium comprises less than about 0.4% polymer. In a preferred embodiment, the sieving medium comprises about 0.35% polymer or less. In other embodiments, the sieving medium can comprise more than 0.5% polymer. The resulting mixture, e.g., the PCR sieving medium, is then repetitively thermocycled as described below to produce one or more PCR products, which are separated, e.g., electrophoretically, in the same sieving medium. Sieving mediums of use in performing PCR, e.g., with nucleic acid separation of the products, are described above.
  • Bench scale in vitro amplification techniques suitable for amplifying sequences to provide a nucleic acid e.g., as a diagnostic indicator for the presence of the sequence, or for subsequent analysis, sequencing or subcloning are known. [0055]
  • In brief, the most common form of in vitro amplification, i.e., PCR amplification, generally involves the use of one strand of the target nucleic acid sequence, e.g., the sequence to be amplified, as a template for producing a large number of complements to that sequence. Generally, two primer sequences complementary to different ends of a segment of the complementary strands of the target sequence hybridize with their respective strands of the target sequence, and in the presence of polymerase enzymes and nucleoside triphosphates, the primers are extended along the target sequence through the action of the polymerase enzyme (in asymmetric PCR protocols, a single primer is used). The extensions are melted from the target sequence by raising the temperature of the reaction mixture, and the process is repeated, this time with the additional copies of the target sequence synthesized in the preceding steps. PCR amplification typically involves repeated cycles of denaturation, hybridization and extension reactions to produce sufficient amounts of the target nucleic acid, all of which are carried out at different temperatures. Typically, melting of the strands, or heat denaturation, involves temperatures ranging from about 90° C. to 100° C. for times ranging from seconds to minutes. The temperature is then cycled down, e.g., to between about 40° C. and 65° C. for annealing of primers, and then cycled up to between about 70° C. and 85° C. for extension of the primers along the target strand. This process if referred to herein as “thermocycling.”[0056]
  • Examples of techniques sufficient to direct persons of skill through in vitro amplification methods at benchtop scales, including the polymerase chain reaction (PCR) the ligase chain reaction (LCR), Qβ-replicase amplification and other RNA polymerase mediated techniques (e.g., NASBA) are found in Berger, Sambrook, and Ausubel, as well as Mullis et al., (1987) U.S. Pat. No. 4,683,202; PCR [0057] Protocols A Guide to Methods and Applications (Innis et al. eds) Academic Press Inc. San Diego, Calif. (1990) (Innis); Arnheim & Levinson (Oct. 1, 1990) C&EN 36-47; The Journal Of NIH Research (1991) 3, 81-94; (Kwoh et al. (1989) Proc. Natl. Acad. Sci. USA 86, 1173; Guatelli et al. (1990) Proc. Natl. Acad. Sci. USA 87, 1874; Lomell et al. (1989) J. Clin. Chem 35, 1826; Landegren et al., (1988) Science 241, 1077-1080; Van Brunt (1990) Biotechnology 8, 291-294; Wu and Wallace, (1989) Gene 4, 560; Barringer et al. (1990) Gene 89, 117, and Sooknanan and Malek (1995) Biotechnology 13: 563-564. Improved methods of cloning in vitro amplified nucleic acids are described in Wallace et al., U.S. Pat. No. 5,426,039. Improved methods of amplifying large nucleic acids by PCR are summarized in Cheng et al. (1994) Nature 369: 684-685 and the references therein, in which PCR amplicons of up to 40 kb are generated. One of skill will appreciate that essentially any RNA can be converted into a double stranded DNA suitable for restriction digestion, PCR expansion and sequencing using reverse transcriptase and a polymerase. See, Ausbel, Sambrook and Berger, all supra.
  • In the present invention, the PCR reactants are mixed with a sieving medium comprising a low polymer concentration, e.g., 0.5% or less. The products are then directly separated, e.g., in a capillary, using the same sieving medium. [0058]
  • In preferred embodiments, the components of the PCR reaction mixture, e.g., a polymerase, nucleotides, and the like, are mixed with a sieving medium, e.g., with a low polymer concentration, in a microfluidic channel, e.g., a channel on a LABCHIP™, as described in more detail below. The apparatus optionally includes one or more additional channels crossing the microfluidic channel and optionally includes fluid (or joule heating) means such as an electrokinetic controller for thermocycling and fluid direction systems, e.g., electrokinetic controllers and/or pressure sources such as vacuum sources, for flowing materials and reagents through the channels. The PCR products are typically electrophoresed through the channels in the same sieving medium used to achieve product separation. Detection regions in the channels and corresponding detectors are also used, e.g., to detect the separated products. [0059]
  • IV. Microfluidic devices comprising a PCR compatible nucleic acid sieving medium [0060]
  • The sieving medium of the invention is typically used in a microfluidic device and the separation and PCR methods described above are preferably performed in a microfluidic device. The sieving medium is typically polymerized in a microscale channel of a microfluidic device, e.g., after the PCR reaction. Alternatively, dynamic sieving mediums, such as Genescan polymers, are used that do not require polymerization in the channel. PCR and separation of the products are both optionally performed in a sieving medium of the present invention in the channels of a microfluidic device. [0061]
  • A variety of microfluidic devices are optionally adapted for use in the present invention, e.g., by designing and configuring the channels as discussed below. These devices are described in various PCT applications and issued U.S. Patents by the inventors and their coworkers, including U.S. Pat. Nos. 5,699,157 (J. Wallace Parce) issued Dec. 16, 1997, 5,779,868 (J. Wallace Parce et al.) issued Jul. 14, 1998, 5,800,690 (Calvin Y. H. Chow et al.) issued Sep. 1, 1998, 5,842,787 (Anne R. Kopf-Sill et al.) issued Dec. 1, 1998, 5,852,495 (J. Wallace Parce) issued Dec. 22, 1998, 5,869,004 (J. Wallace Parce et al.) issued Feb. 9, 1999, 5,876,675 (Colin B. Kennedy) issued Mar. 2, 1999, 5,880,071 (J. Wallace Parce et al.) issued Mar. 9, 1999, 5,882,465 (Richard J. McReynolds) issued Mar. 16, 1999, 5,885,470 (J. Wallace Parce et al.) issued Mar. 23, 1999, 5,942,443 (J. Wallace Parce et al.) issued Aug. 24, 1999, 5,948,227 (Robert S. Dubrow) issued Sep. 7, 1999, 5,955,028 (Calvin Y. H. Chow) issued Sep. 21, 1999, 5,957,579 (Anne R. Kopf-Sill et al.) issued Sep. 28, 1999, 5,958,203 (J. Wallace Parce et al.) issued Sep. 28, 1999, 5,958,694 (Theo T. Nikiforov) issued Sep. 28, 1999, and 5,959,291 (Morten J. Jensen) issued Sep. 28, 1999; and published PCT applications, such as, WO 98/00231, WO 98/00705, WO 98/00707, WO 98/02728, WO 98/05424, WO 98/22811, WO 98/45481, WO 98/45929, WO 98/46438, and WO 98/49548, WO 98/55852, WO 98/56505, WO 98/56956, WO 99/00649, WO 99/10735, WO 99/12016, WO 99/16162, WO 99/19056, WO 99/19516, WO 99/29497, WO 99/31495, WO 99/34205, WO 99/43432, and WO 99/44217. [0062]
  • In particular, the use of sieving mediums in PCR and nucleic acid separations in microfluidic devices is described in U.S. Ser. No. 09/093,832, by Burd Mehta, filed Jun. 8, 1998. In addition, various other elements are optionally included in the device, such as particle sets, separation gels, antibodies, enzymes, substrates, and the like. These optional elements are used in performing various assays, such as nucleic acid sequencing. For example, the use of particle sets in nucleic acid sequencing is described, e.g., in WO 00/50172, published Aug. 31, 2000, entitled “Manipulation of Microparticles In Microfluidic Systems,” by Burd Mehta et al. [0063]
  • Complete integrated systems with fluid handling, signal detection, sample storage and sample accessing are also available. For example WO 98/00231 (supra) provides pioneering technology for the integration of microfluidics and sample selection and manipulation. [0064]
  • One aspect of the invention is the placement of the sieving medium in selected channels or channel regions of a microfluidic substrate. These materials (or precursors of the materials, e.g., monomers polymerized in the device as discussed above) are loaded into microfluidic components by electrokinesis, by pressurized pumping, by centrifugal force, or capillary flow. The present invention provides methods of DNA separation and PCR that are both compatible with the sieving mediums of the invention. Therefore, the sieving medium is typically loaded throughout the entire device. However if other assays are steps are desired, e.g., DNA sequencing reactions, certain channels are optionally filled with reagents for the desired assay or left empty. [0065]
  • Several methods of providing fluidic regions in selected regions of a channel, or selected channels are provided. In a first aspect, multiple microfluidic regions are filled with a sieving medium, e.g., in an unpolymerized solution that, upon polymerization, forms a sieving matrix. Elements of the microfluidic device such as microfluidic channels are filled with the sieving medium by forcing the fluid into the channel under pressure, or by moving the fluid into the channel electrokinetically. In one embodiment, the first fluid polymerizes upon exposure to light (i.e., the fluid comprises a “photopolymerizable” polymer). The fluid is then selectively exposed to light (e.g., using photomasking techniques) in those regions where a polymerized gel is desired. Unpolymerized fluid is then optionally washed out of the unselected regions of the microfluidic device, or into a waste reservoir using electrokinetic flow or pressure. [0066]
  • For either the thermal or photopolymerization methods herein, monomer is pumped, e.g., in aqueous buffer, into a channel or channel region using electroosmotic flow, or using a pressure gradient. After selective exposure to light or heat, as appropriate, unpolymerized materials are removed, typically using electroosmotic flow, but optionally using a pressure gradient, from regions where monomer material is undesirable. [0067]
  • In another embodiment, a sieving matrix is deposited throughout a channel or channels of a microfluidic device in a form which is subject to electroosmosis (i.e., the matrix moves electrokinetically in the channel). [0068]
  • In an additional embodiment, a sieving medium is loaded into multiple channels of a microfluidic device, e.g., under pressure, and polymerized in place. Selective components which solubilize the polymerized gel are then loaded (e.g., electrokinetically or under pressure) into channel regions where polymerized product is not desired, i.e., channels in which other assays are to be performed. The selected components dissolve the polymerized gel. Example of solubilization compounds include acids, bases and other chemicals. In one preferred embodiment, at least two compounds are used to dissolve polymerized products, where both products need to be present to dissolve the polymer. This provides for fine control of dissolution, e.g., where each chemical is under separate electrokinetic control. An example of such a chemical pair is DTT(N,N′-bis(acrylol)cystamine or (1,2-dihydroxyethylene-bis-acrylamide) [DHEBA] and sodium periodiate or calcium alginate+EDTA or TCEP-HCL and N,N′-bis(acryloyl)cystamine. A variety of such materials are known. [0069]
  • The sieving medium of the invention is particularly useful for performing experimental or diagnostic procedures which combine nucleic acid amplification and product separatory aspects. For example, PCR is performed in a microfluidic channel comprising a sieving medium as described herein, followed by separation in the same sieving medium, e.g., in the same or in a different channel region. [0070]
  • In one aspect, PCR or other thermal reaction reagents (e.g., LCR reagents) such as thermostable polymerase, DNA template, primers, nucleotides and buffers are mixed, e.g., with a sieving medium, in a microchannel or chamber, with the entire microfluidic substrate (e.g., a LABCHIP™ from Caliper Technologies) being subject to repeated cycles of heating and cooling, e.g., on a thermocycler or by switching between a hot plate and a heat sink. [0071]
  • In a second more preferred embodiment, variations in channel thickness and/or voltage are used selectively to heat selected regions of a channel which contain a PCR reaction. PCR amplification is particularly well suited to this use in the apparatus, methods and systems of the invention. Thermocycling amplification methods, including PCR and LCR, are conveniently performed in microscale devices, making iterative fluidic operations involving PCR well suited to use in methods and devices of the present invention (see also, U.S. Pat. Nos. 5,498,392 and 5,587,128 to Willingham et al.). Accordingly, in one preferred embodiment, generation of amplicons such as sequencing templates using PCR, or direct sequencing of nucleic acids by PCR (e.g., using nuclease digestion as described supra) is performed with the integrated systems and devices of the invention. [0072]
  • Thermocycling in microscale devices, including thermocycling by joule heating is described in WO 99/12016, entitled “ELECTRICAL CURRENT FOR CONTROLLING FLUID PARAMETERS IN MICROCHANNELS” published Mar. 11, 1999 by Calvin Chow, Anne R. Kopf-Sill and J. Wallace Parce; in 08/977,528, filed Nov. 25, 1997; in WO 98/45481, entitled “CLOSED-LOOP BIOCHEMICAL ANALYZERS,” published Oct. 15, 1998; and in 09/287,069, entitled INEFFICIENT FAST PCR, filed Apr. 6, 1999 by Kopf-Sill. In brief, energy is provided to heat fluids, e.g., samples, analytes, buffers and reagents, in desired locations of the substrates in an efficient manner by application of electric current to fluids in microchannels. Thus, the present invention optionally uses power sources that pass electrical current through a first channel region for heating purposes, as well as for material transport. In exemplary embodiments, fluid passes through a channel of a desired cross-section (e.g., diameter) to enhance thermal transfer of energy from the current to the fluid. The channels can be formed on almost any type of substrate material such as, for example, amorphous materials (e.g., glass, plastic, silicon), composites, multi-layered materials, combinations thereof, and the like. [0073]
  • In general, electric current passing through the fluid in a channel produces heat by dissipating energy through the electrical resistance of the fluid. Power dissipates as the current passes through the fluid and goes into the fluid as energy as a function of time to heat the fluid. The following mathematical expression generally describes a relationship between power, electrical current, and fluid resistance: [0074]
  • POWER=I2R
  • where [0075]
  • POWER=power dissipated in fluid; [0076]
  • I=electric current passing through fluid; and [0077]
  • R=electric resistance of fluid. [0078]
  • The above equation provides a relationship between power dissipated (“POWER”) to current (“I”) and resistance (“R”). In some of the embodiments, which are directed toward moving fluid in channels, e.g., to provide mixing, electrophoretic separation, or the like, a portion of the power goes into kinetic energy of moving the fluid through the channel. However, it is also possible to use a selected portion of the power to controllably heat fluid in a channel or selected channel regions. A channel region suitable for heating is often narrower or smaller in cross-section than other channel regions in the channel structure, as a smaller cross-section provides higher resistance in the fluid, which increases the temperature of the fluid as electric current passes through. Alternatively, the electric current is increased across the length of the channel by increased voltage, which also increases the amount of power dissipated into the fluid to correspondingly increase fluid temperature. [0079]
  • To selectively control the temperature of fluid at a region of the channel, a power supply applies voltage and/or current in one of many ways. For instance, a power supply can apply direct current (i.e., DC) or alternating current (AC), which passes through the channel and into a channel region which is smaller in cross-section, thereby heating fluid in the region. This current is selectively adjusted in magnitude to complement any voltage or electric field that is applied to move fluid in and out of the region. AC current, voltage, and/or frequency can be adjusted, for example, to heat the fluid without substantially moving the fluid. Alternatively, a power supply can apply a pulse or impulse of current and/or voltage, which passes through the channel and into a channel region to heat fluid in the region. This pulse is selectively adjusted to complement any voltage or electric field that is applied to move fluid in and out of the region. Pulse width, shape, and/or intensity can be adjusted, for example, to heat the fluid substantially without moving the fluid or to heat the fluid while moving the fluid. Still further, the power supply can apply any combination of DC, AC, and pulse, depending upon the application. In practice, direct application of electric current to fluids in the microchannels of the invention results in extremely rapid and easily controlled changes in temperature. [0080]
  • A controller or computer such as a personal computer monitors the temperature of the fluid in the region of the channel where the fluid is heated. The controller or computer receives current and voltage information from, for example, the power supply and identifies or detects temperature of fluid in the region of the channel. Depending upon the desired temperature of fluid in the region, the controller or computer adjusts voltage and/or current to meet the desired fluid temperature. The controller or computer also can be set to be “current controlled” or “voltage controlled” or “power controlled” depending upon the application. [0081]
  • The region which is heated can be a “coil” which is optionally in a planar arrangement. Transfer of heat from the coil to a reaction channel through a substrate material is used to heat the reaction channel. Alternatively, the coil itself is optionally the reaction channel. [0082]
  • A voltage is applied between regions of the coil to direct current through the fluid for heating purposes. In particular, a power supply provides a voltage differential between regions of the coil. Current flows between the regions and traverses a plurality of coils or coil loops (which can be planar), which are defined by a substrate. Shape and size of the coils can influence an ability of current to heat the fluid in the coil. As current traverses through the fluid, energy is transferred to the fluid for heating purposes. Cooling coils can also be used. As a cooling coil, a fluid traverses from region to region in the coil, which can be placed to permit heat transfer through a substrate from a sample. The cooling fluid can be a variety of substances including liquids and gases. As merely an example, the cooling fluid includes aqueous solutions, liquid or gaseous nitrogen, and others. The cooling fluid can be moved between regions using any of the techniques described herein, and others. Further details are found in Chow et al., supra. [0083]
  • The introduction of electrical current into fluid causes heat (this procedure is referred to as “Joule heating”). In the examples of fluid movement herein where thermal effects are not desired, the heating effect is minimal because, at the small currents employed, heat is rapidly dissipated into the chip itself. By substantially increasing the current across the channel, rapid temperature changes are induced that can be monitored by conductivity. At the same time, the fluid can be kept static in the channel by using alternating instead of direct current. Because nanoliter volumes of fluid have tiny thermal mass, transitions between temperatures can be extremely short. Oscillations between any two temperatures above 0° C. and below 100° C. in 100 milliseconds have been performed. [0084]
  • Joule heating in microchannels is an example of how benchtop methods can be dramatically improved in the formats provided herein. PCR takes hours to perform currently, primarily because it takes a long time for conventional heating blocks to oscillate between temperatures. In addition, reagent cost is an obstacle to massive experimentation. Both these parameters are altered by orders of magnitude in the LabChip™ format. [0085]
  • In one aspect, PCR reaction conditions are controlled as a function of channel geometry. Microfabrication methods permit the manufacture of channels that have precise variations in cross sectional area. Since the channel resistance is inversely proportional to the cross sectional area, the temperature varies with the width and depth of the channel for a given flow of current. As fluid moves through a structure of varying cross sectional area, its temperature will change, depending on the dimensions of the channel at any given point. The amount of time it experiences a given temperature will be determined by the velocity of the fluid flow, and the length of channel with those dimensions. This concept is illustrated in FIG. 2. Nucleic acids of typical lengths have a low diffusion coefficient (about 10[0086] −7 cm/sec2). Thus over the time frame necessary to affect amplification, DNA will only diffuse a few hundred microns. In a given channel, reactions of a few nanoliters will occupy a few millimeters. Thus in devices of convenient length (a few centimeters), many PCR reactions can be performed concurrently yielding new amplification products every few seconds per channel. In parallel formats, hundreds of separate reactions can be performed simultaneously. Because of its simplicity, throughput, and convenience, this amplification unit is a preferred feature of many assays herein.
  • In FIG. 2, amplification reactions are performed concurrently in series using biased alternating current to heat the fluid inside the channel and move material through it. The time for each step of the reaction is controlled by determining the speed of movement and the length of channel having particular widths. Flow can be reversed to allow a single small channel region to be used for many separate amplifications. [0087]
  • As depicted, several samples are run simultaneously in [0088] channel 210. Sample 215 is in narrow channel region 220; in operation, this region is heated to, e.g., 95° C. (hot enough to denature nucleic acids present in sample 215, but cool enough that thermostable reagents such as Taq DNA polymerase are relatively stable due to the relative size of region 220 and the applied current. Concurrently, wide channel region 230 is heated, e.g., to 60° C. (cool enough for binding of primers in sample 225 and initiation of polymerase extension), due to the relative size of region 230 and the applied current. Concurrently, intermediate channel region 235 is heated, e.g., to 72° C. (hot enough to prevent unwanted non-specific primer-target nucleic acid interactions in sample 240 and cool enough to permit continued polymerase extension), due to the relative size of region 235 and the applied current. This process can be concurrently carried out with a plurality of additional channel regions such as narrow region 245, wide region 250 and intermediate region 255, with samples 260, 265 and 270.
  • Where possible, direct detection of amplified products can be employed. For example, differentially labeled competitive probe hybridization is used for single nucleotide discrimination. Alternatively, molecular beacons or single nucleotide polymerase extension can be employed. Homogeneous detection by fluorescence polarization spectroscopy can also be utilized (fluorescence polarization has been used to distinguish between labeled small molecules free in solution or bound to protein receptors). [0089]
  • The present invention provides the ability to integrate complex functions such as PCR and nucleic acid separation in a single format, e.g., in a microfluidic device. PCR and nucleic acid separations are optionally performed in the same sieving medium, therefore making it possible to perform both functions in a single channel of a microfluidic device. [0090]
  • For example, a Caliper LabChip™ is optionally used to load DNA template, run the PCR reaction, and then size the resulting PCR product by gel separation. FIG. 1 provides a schematic of an example device. Device [0091] 100 is optionally filled with a sieving medium as described above, e.g., a sieving gel. The sieving medium provides a continuous fluid phase throughout the device, such that PCR is optionally carried out by joule heating in one channel, e.g., channel 101, and product separation in another channel, e.g., channel 103. Alternatively, the entire device is thermocycled to perform PCR. PCR is thereby carried out in the sieving medium. PCR reagents and a target nucleic acid are added to the sieving medium if not already incorporated therein, e.g., into channel 101. Cross channel 101 is optionally a PCR channel as described herein and shown in FIG. 2. The loaded device is typically placed on a thermocycler (MJ Research) and the temperature is typically cycled to amplify the target nucleic acid. At the end of the cycling procedure, the chip is typically placed on a microscope detection station and the product is electrokinetically injected into separation channel 103. For example, voltages are applied at wells 107 and 109 to electrokinetically separate the product nucleic acids. An example spectrum showing separated nucleic acid peaks is provided in FIG. 3.
  • It will be appreciated that separations chips comprising a single sieving matrix are produced as described above. However, additional fluidic phases are optionally placed in additional channels or channel regions in fluid communication with a channel region comprising the PCR sieving mixture for electrophoretic or electroosmotic movement of the PCR components or products in the chips. For example, in some aspects a PCR reaction product is selected for further manipulations such as cloning, sequencing or the like, all of which are optionally performed in the same device (see also, U.S. Ser. No. 60/068,311, entitled “Closed Loop Biochemical Analyzer” by Knapp, filed Dec. 19, 1997 and “Closed Loop Biochemical Analyzers” by Knapp et al. U.S. Ser. No. 09/054,962, filed Apr. 3, 1998). [0092]
  • While the foregoing invention has been described in some detail for purposes of clarity and understanding, it will be clear to one skilled in the art from a reading of this disclosure that various changes in form and detail can be made without departing from the true scope of the invention. For example, all the techniques and apparatus described above may be used in various combinations. All publications, patents, patent applications, or other documents cited in this application are incorporated by reference in their entirety for all purposes to the same extent as if each individual publication, patent, patent application, or other document were individually indicated to be incorporated by reference for all purposes. [0093]

Claims (35)

What is claimed is:
1. A microfluidic device for performing PCR and nucleic acid separations, the device comprising at least one microscale channel and a sieving medium, which sieving medium is disposed within the at least one microscale channel and comprises a polymer solution, which polymer solution comprises less than about 0.5% polymer.
2. The microfluidic device of claim 1, wherein the polymer solution comprises less than about 0.4% polymer.
3. The microfluidic device of claim 1, wherein the polymer solution comprises about 0.35% polymer or less.
4. The microfluidic device of claim 1, wherein the polymer solution comprises acrylamide.
5. The microfluidic device of claim 4, wherein the acrylamide comprises linear acrylamide, polyacrylamide, polydimethylacrylamide, or polydimethylacrylamide/coacrylic acid.
6. The microfluidic device of claim 1, wherein the polymer solution comprises agarose, methyl cellulose, polyethylene oxide, hydroxycellulose, or hydroxy ethyl cellulose.
7. The microfluidic device of claim 1, further comprising one or more proteins, nucleic acids, PCR reaction components, or PCR products disposed within the at least one microfluidic channel.
8. The microfluidic device of claim 7, wherein the PCR reaction components comprise one or more of: a thermostable DNA polymerase, a plurality of nucleotides, a nucleic acid template, a primer which hybridizes to the nucleic acid template, or Mg++.
9. A method of separating polynucleotides, the method comprising:
(i) providing two or more polynucleotides;
(ii) providing a sieving medium, which sieving medium comprises a polymer solution, which polymer solution comprises less than about 0.5% polymer;
(iii) allowing the two or more polynucleotides to migrate through the sieving medium, thereby separating the two or more polynucleotides.
10. The method of claim 9, wherein the polynucleotides comprise one or more PCR products, RNA, or DNA.
11. The method of claim 9, wherein the polymer solution comprises less than about 0.4% polymer.
12. The method of claim 9, wherein the polymer solution comprises about 0.35% polymer or less.
13. The method of claim 9, wherein the polymer solution comprises acrylamide.
14. The method of claim 13, wherein the acrylamide comprises linear acrylamide, polyacrylamide, polydimethylacrylamide, or polydimethylacrylamide/coacrylic acid.
15. The method of claim 9, wherein the polymer solution comprises agarose, methyl cellulose, polyethylene oxide, hydroxycellulose, or hydroxy ethyl cellulose.
16. The method of claim 9, further comprising introducing the sieving medium into a microfluidic channel and allowing the two or more polynucleotides to migrate through the sieving medium in the microfluidic channel.
17. The method of claim 9, wherein the separating comprises electrophoretically separating the two or more polynucleotides.
18. A method of performing PCR and separating one or more PCR products, the method comprising:
(i) mixing one or more PCR reaction components with a sieving medium to provide a PCR sieving medium, wherein the sieving medium comprises a polymer solution, which polymer solution comprises less than about 0.5% polymer; and
(ii) thermocycling the PCR sieving medium to produce one or more PCR products; and,
(iii) separating the one or more PCR products by flowing the one or more PCR products through the sieving medium.
19. The method of claim 18, wherein the polymer solution comprises less than about 0.4% polymer.
20. The method of claim 19, wherein the polymer solution comprises about 0.35% polymer or less.
21. The method of claim 18, wherein the polymer solution comprises acrylamide.
22. The method of claim 21, wherein the acrylamide comprises linear acrylamide, polyacrylamide, polydimethylacrylamide, or polydimethylacrylamide/coacrylic acid.
23. The method of claim 28, wherein the polymer solution comprises agarose, methyl cellulose, polyethylene oxide, hydroxycellulose, or hydroxy ethyl cellulose.
24. The method of claim 18, wherein the one or more PCR reaction components comprise one or more of: a thermostable DNA polymerase, a plurality of nucleotides, a nucleic acid template, a primer which hybridizes to the nucleic acid template, or Mg++.
25. The method of claim 18, comprising mixing the PCR reaction components with the sieving medium in a microfluidic channel.
26. The method of claim 25, further comprising separating the one or more PCR products by flowing the one or more PCR products through the sieving medium in the microfluidic channel.
27. The method of claim 26, wherein separating comprises electrophoretically separating.
28. A nucleic acid sieving medium, which medium comprises one or more polynucleotides, one or more PCR reagents, and a polymer solution, which polymer solution comprises less than about 0.5% polymer.
29. The sieving medium of claim 28, wherein the polymer solution comprises less than about 0.4% polymer.
30. The sieving medium of claim 29, wherein the polymer solution comprises about 0.35% polymer or less.
31. The sieving medium of claim 28, wherein the polymer solution comprises acrylamide.
32. The sieving medium of claim 31, wherein the acrylamide comprises linear acrylamide, polyacrylamide, polydimethylacrylamide, or polydimethylacrylamide/coacrylic acid.
33. The sieving medium of claim 28, wherein the polymer solution comprises agarose, methyl cellulose, polyethylene oxide, hydroxycellulose, or hydroxy ethyl cellulose.
34. The sieving medium of claim 28, wherein the one or more PCR reaction components comprise one or more of: a thermostable DNA polymerase, a plurality of nucleotides, a nucleic acid template, a primer which hybridizes to the nucleic acid template, or Mg++.
35. The sieving medium of claim 28, wherein the one or more polynucleotides comprise DNA, RNA, or PCR products.
US09/792,297 2000-03-20 2001-02-23 PCR compatible nucleic acid sieving medium Abandoned US20020012971A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09/792,297 US20020012971A1 (en) 2000-03-20 2001-02-23 PCR compatible nucleic acid sieving medium
US10/659,423 US7521186B2 (en) 2000-03-20 2003-09-10 PCR compatible nucleic acid sieving matrix

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19077300P 2000-03-20 2000-03-20
US09/792,297 US20020012971A1 (en) 2000-03-20 2001-02-23 PCR compatible nucleic acid sieving medium

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/659,423 Division US7521186B2 (en) 2000-03-20 2003-09-10 PCR compatible nucleic acid sieving matrix

Publications (1)

Publication Number Publication Date
US20020012971A1 true US20020012971A1 (en) 2002-01-31

Family

ID=26886426

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/792,297 Abandoned US20020012971A1 (en) 2000-03-20 2001-02-23 PCR compatible nucleic acid sieving medium
US10/659,423 Expired - Fee Related US7521186B2 (en) 2000-03-20 2003-09-10 PCR compatible nucleic acid sieving matrix

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/659,423 Expired - Fee Related US7521186B2 (en) 2000-03-20 2003-09-10 PCR compatible nucleic acid sieving matrix

Country Status (1)

Country Link
US (2) US20020012971A1 (en)

Cited By (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060003439A1 (en) * 2004-07-02 2006-01-05 Ismagilov Rustem F Microfluidic system
US20060014185A1 (en) * 2004-06-29 2006-01-19 Wallac Oy Integrated nucleic acid analysis
US7001853B1 (en) 2002-08-30 2006-02-21 Caliper Life Sciences, Inc. Flow control of photo-polymerizable resin
US20060153924A1 (en) * 2003-03-31 2006-07-13 Medical Research Council Selection by compartmentalised screening
US20070092914A1 (en) * 2004-03-31 2007-04-26 Medical Research Council, Harvard University Compartmentalised screening by microfluidic control
US20090020556A1 (en) * 2007-07-19 2009-01-22 Kabir James Mukaddam Metering assembly and method of dispensing fluid
US20090197772A1 (en) * 2004-03-31 2009-08-06 Andrew Griffiths Compartmentalised combinatorial chemistry by microfluidic control
US20090197248A1 (en) * 2004-10-08 2009-08-06 President And Fellows Of Harvard College Vitro evolution in microfluidic systems
US20100022414A1 (en) * 2008-07-18 2010-01-28 Raindance Technologies, Inc. Droplet Libraries
US20100078077A1 (en) * 2006-12-19 2010-04-01 Ismagilov Rustem F Spacers for Microfluidic Channels
US20100163109A1 (en) * 2007-02-06 2010-07-01 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US20100186841A1 (en) * 2009-01-23 2010-07-29 Formulatrix, Inc. Microfluidic dispensing assembly
US20100210479A1 (en) * 2003-03-31 2010-08-19 Medical Research Council Method of synthesis and testing of cominatorial libraries using microcapsules
US20100227767A1 (en) * 2007-07-26 2010-09-09 Boedicker James Q Stochastic confinement to detect, manipulate, and utilize molecules and organisms
US20100233026A1 (en) * 2002-05-09 2010-09-16 Ismagliov Rustem F Device and method for pressure-driven plug transport and reaction
US20100252118A1 (en) * 2007-04-19 2010-10-07 Seth Fraden Manipulation of fluids, fluid components and reactions in microfluidic systems
EP2302389A1 (en) * 2002-05-09 2011-03-30 The University of Chicago Device and method for pressure-driven plug transport and reaction
US20110112503A1 (en) * 2008-06-04 2011-05-12 Ismagilov Rustem F Chemistrode, a plug-based microfluidic device and method for stimulation and sampling with high temporal, spatial, and chemical resolution
US20110223605A1 (en) * 2009-06-04 2011-09-15 Lockheed Martin Corporation Multiple-sample microfluidic chip for DNA analysis
US8528589B2 (en) 2009-03-23 2013-09-10 Raindance Technologies, Inc. Manipulation of microfluidic droplets
US8535889B2 (en) 2010-02-12 2013-09-17 Raindance Technologies, Inc. Digital analyte analysis
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US8961764B2 (en) 2010-10-15 2015-02-24 Lockheed Martin Corporation Micro fluidic optic design
US9012390B2 (en) 2006-08-07 2015-04-21 Raindance Technologies, Inc. Fluorocarbon emulsion stabilizing surfactants
US9150852B2 (en) 2011-02-18 2015-10-06 Raindance Technologies, Inc. Compositions and methods for molecular labeling
US9273308B2 (en) 2006-05-11 2016-03-01 Raindance Technologies, Inc. Selection of compartmentalized screening method
US9322054B2 (en) 2012-02-22 2016-04-26 Lockheed Martin Corporation Microfluidic cartridge
US9328344B2 (en) 2006-01-11 2016-05-03 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US9364803B2 (en) 2011-02-11 2016-06-14 Raindance Technologies, Inc. Methods for forming mixed droplets
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US9415392B2 (en) 2009-03-24 2016-08-16 The University Of Chicago Slip chip device and methods
US9447461B2 (en) 2009-03-24 2016-09-20 California Institute Of Technology Analysis devices, kits, and related methods for digital quantification of nucleic acids and other analytes
US9464319B2 (en) 2009-03-24 2016-10-11 California Institute Of Technology Multivolume devices, kits and related methods for quantification of nucleic acids and other analytes
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
US9562897B2 (en) 2010-09-30 2017-02-07 Raindance Technologies, Inc. Sandwich assays in droplets
EP3092055A4 (en) * 2014-01-09 2017-08-09 The Board of Trustees of the Leland Stanford Junior University Simultaneous extraction and separation of rna and dna from single cells using electrophoretic techniques
US10196700B2 (en) 2009-03-24 2019-02-05 University Of Chicago Multivolume devices, kits and related methods for quantification and detection of nucleic acids and other analytes
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US10520500B2 (en) 2009-10-09 2019-12-31 Abdeslam El Harrak Labelled silica-based nanomaterial with enhanced properties and uses thereof
US10533998B2 (en) 2008-07-18 2020-01-14 Bio-Rad Laboratories, Inc. Enzyme quantification
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US10837883B2 (en) 2009-12-23 2020-11-17 Bio-Rad Laboratories, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
US11174509B2 (en) 2013-12-12 2021-11-16 Bio-Rad Laboratories, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11193176B2 (en) 2013-12-31 2021-12-07 Bio-Rad Laboratories, Inc. Method for detecting and quantifying latent retroviral RNA species
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
US12097475B2 (en) 2004-07-02 2024-09-24 The University Of Chicago Microfluidic system

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048734A (en) 1995-09-15 2000-04-11 The Regents Of The University Of Michigan Thermal microvalves in a fluid flow method
US6692700B2 (en) 2001-02-14 2004-02-17 Handylab, Inc. Heat-reduction methods and systems related to microfluidic devices
US7323140B2 (en) 2001-03-28 2008-01-29 Handylab, Inc. Moving microdroplets in a microfluidic device
US7829025B2 (en) 2001-03-28 2010-11-09 Venture Lending & Leasing Iv, Inc. Systems and methods for thermal actuation of microfluidic devices
KR100959101B1 (en) * 2003-02-20 2010-05-25 삼성전자주식회사 Polymerase chain reaction device and method for regulating opening or shutting of inlet and outlet of PCR device
WO2004094986A2 (en) * 2003-04-16 2004-11-04 Handylab, Inc. System and method for electrochemical detection of biological compounds
EP2402089A1 (en) 2003-07-31 2012-01-04 Handylab, Inc. Processing particle-containing samples
US8852862B2 (en) 2004-05-03 2014-10-07 Handylab, Inc. Method for processing polynucleotide-containing samples
JP5344817B2 (en) 2004-05-03 2013-11-20 ハンディーラブ インコーポレイテッド Processing of samples containing polynucleotides
EP1637228A1 (en) * 2004-09-16 2006-03-22 Roche Diagnostics GmbH Method an apparatus for performing rapid thermo cycling as well as a micro fabricated system
ES2692380T3 (en) 2006-03-24 2018-12-03 Handylab, Inc. Method to perform PCR with a cartridge with several tracks
US7998708B2 (en) 2006-03-24 2011-08-16 Handylab, Inc. Microfluidic system for amplifying and detecting polynucleotides in parallel
US10900066B2 (en) 2006-03-24 2021-01-26 Handylab, Inc. Microfluidic system for amplifying and detecting polynucleotides in parallel
US11806718B2 (en) 2006-03-24 2023-11-07 Handylab, Inc. Fluorescence detector for microfluidic diagnostic system
US8883490B2 (en) 2006-03-24 2014-11-11 Handylab, Inc. Fluorescence detector for microfluidic diagnostic system
WO2008061165A2 (en) 2006-11-14 2008-05-22 Handylab, Inc. Microfluidic cartridge and method of making same
US20090136385A1 (en) 2007-07-13 2009-05-28 Handylab, Inc. Reagent Tube
US9618139B2 (en) 2007-07-13 2017-04-11 Handylab, Inc. Integrated heater and magnetic separator
USD621060S1 (en) 2008-07-14 2010-08-03 Handylab, Inc. Microfluidic cartridge
US9186677B2 (en) 2007-07-13 2015-11-17 Handylab, Inc. Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples
US8105783B2 (en) 2007-07-13 2012-01-31 Handylab, Inc. Microfluidic cartridge
US8182763B2 (en) 2007-07-13 2012-05-22 Handylab, Inc. Rack for sample tubes and reagent holders
WO2009012185A1 (en) 2007-07-13 2009-01-22 Handylab, Inc. Polynucleotide capture materials, and methods of using same
US8287820B2 (en) 2007-07-13 2012-10-16 Handylab, Inc. Automated pipetting apparatus having a combined liquid pump and pipette head system
US8133671B2 (en) 2007-07-13 2012-03-13 Handylab, Inc. Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples
USD618820S1 (en) 2008-07-11 2010-06-29 Handylab, Inc. Reagent holder
USD787087S1 (en) 2008-07-14 2017-05-16 Handylab, Inc. Housing
AU2010258715B2 (en) * 2009-06-12 2015-04-09 Perkinelmer Health Sciences, Inc. Rehydratable matrices for dry storage of TAQ polymerase in a microfluidic device
CN106148512B (en) 2011-04-15 2020-07-10 贝克顿·迪金森公司 Scanning real-time microfluidic thermocycler and method for synchronized thermocycling and scanning optical detection
RU2622432C2 (en) 2011-09-30 2017-06-15 Бектон, Дикинсон Энд Компани Unified strip for reagents
USD692162S1 (en) 2011-09-30 2013-10-22 Becton, Dickinson And Company Single piece reagent holder
CN104040238B (en) 2011-11-04 2017-06-27 汉迪拉布公司 Polynucleotides sample preparation apparatus
JP6262152B2 (en) 2012-02-03 2018-01-17 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company External file for distribution of molecular diagnostic tests and determination of compatibility between tests

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390403A (en) 1981-07-24 1983-06-28 Batchelder J Samuel Method and apparatus for dielectrophoretic manipulation of chemical species
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5135855A (en) * 1986-09-03 1992-08-04 The United States Of America As Represented By The Department Of Health And Human Services Rapid, versatile and simple system for expressing genes in eukaryotic cells
US4908112A (en) 1988-06-16 1990-03-13 E. I. Du Pont De Nemours & Co. Silicon semiconductor wafer for analyzing micronic biological samples
US5188963A (en) * 1989-11-17 1993-02-23 Gene Tec Corporation Device for processing biological specimens for analysis of nucleic acids
US5264101A (en) 1989-11-06 1993-11-23 Applied Biosystems, Inc. Capillary electrophoresis molecular weight separation of biomolecules using a polymer-containing solution
US5164055A (en) * 1990-01-29 1992-11-17 Applied Biosystems, Inc. High-viscosity polymer matrix and methods
US5126022A (en) 1990-02-28 1992-06-30 Soane Tecnologies, Inc. Method and device for moving molecules by the application of a plurality of electrical fields
US5770029A (en) 1996-07-30 1998-06-23 Soane Biosciences Integrated electrophoretic microdevices
US5750015A (en) 1990-02-28 1998-05-12 Soane Biosciences Method and device for moving molecules by the application of a plurality of electrical fields
WO1992019960A1 (en) 1991-05-09 1992-11-12 Nanophore, Inc. Methods for the electrophoretic separation of nucleic acids and other linear macromolecules in gel media with restrictive pore diameters
US5587128A (en) 1992-05-01 1996-12-24 The Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification devices
US5304487A (en) 1992-05-01 1994-04-19 Trustees Of The University Of Pennsylvania Fluid handling in mesoscale analytical devices
US5637469A (en) 1992-05-01 1997-06-10 Trustees Of The University Of Pennsylvania Methods and apparatus for the detection of an analyte utilizing mesoscale flow systems
US5498392A (en) 1992-05-01 1996-03-12 Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification device and method
RU2048522C1 (en) * 1992-10-14 1995-11-20 Институт белка РАН Method of nucleic acid copying, method of their expression and a medium for their realization
US5874212A (en) 1993-05-13 1999-02-23 Thomas Jefferson University Detection of single base mutations and other variations in double stranded DNA by conformation-sensitive gel electrophoresis
US5426039A (en) 1993-09-08 1995-06-20 Bio-Rad Laboratories, Inc. Direct molecular cloning of primer extended DNA containing an alkane diol
US6001229A (en) 1994-08-01 1999-12-14 Lockheed Martin Energy Systems, Inc. Apparatus and method for performing microfluidic manipulations for chemical analysis
US5571410A (en) 1994-10-19 1996-11-05 Hewlett Packard Company Fully integrated miniaturized planar liquid sample handling and analysis device
US5585069A (en) 1994-11-10 1996-12-17 David Sarnoff Research Center, Inc. Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis
US5603351A (en) 1995-06-07 1997-02-18 David Sarnoff Research Center, Inc. Method and system for inhibiting cross-contamination in fluids of combinatorial chemistry device
US5856174A (en) * 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US6395887B1 (en) * 1995-08-01 2002-05-28 Yale University Analysis of gene expression by display of 3'-end fragments of CDNAS
US5716825A (en) 1995-11-01 1998-02-10 Hewlett Packard Company Integrated nucleic acid analysis system for MALDI-TOF MS
US5942443A (en) 1996-06-28 1999-08-24 Caliper Technologies Corporation High throughput screening assay systems in microscale fluidic devices
US6399023B1 (en) 1996-04-16 2002-06-04 Caliper Technologies Corp. Analytical system and method
US5885470A (en) 1997-04-14 1999-03-23 Caliper Technologies Corporation Controlled fluid transport in microfabricated polymeric substrates
EP0907412B1 (en) 1996-06-28 2008-08-27 Caliper Life Sciences, Inc. High-throughput screening assay systems in microscale fluidic devices
US5779868A (en) 1996-06-28 1998-07-14 Caliper Technologies Corporation Electropipettor and compensation means for electrophoretic bias
CN1329729C (en) 1996-06-28 2007-08-01 卡钳生命科学股份有限公司 Electropipettor and compensation means for electrophoretic bias
US5800690A (en) 1996-07-03 1998-09-01 Caliper Technologies Corporation Variable control of electroosmotic and/or electrophoretic forces within a fluid-containing structure via electrical forces
US5699157A (en) 1996-07-16 1997-12-16 Caliper Technologies Corp. Fourier detection of species migrating in a microchannel
US6447727B1 (en) 1996-11-19 2002-09-10 Caliper Technologies Corp. Microfluidic systems
US5964995A (en) 1997-04-04 1999-10-12 Caliper Technologies Corp. Methods and systems for enhanced fluid transport
EP0972082A4 (en) 1997-04-04 2007-04-25 Caliper Life Sciences Inc Closed-loop biochemical analyzers
KR100351531B1 (en) 1997-04-25 2002-09-11 캘리퍼 테크놀로지스 코포레이션 Microfludic devices incorporating improved channel geometries
US5976336A (en) 1997-04-25 1999-11-02 Caliper Technologies Corp. Microfluidic devices incorporating improved channel geometries
US6090251A (en) 1997-06-06 2000-07-18 Caliper Technologies, Inc. Microfabricated structures for facilitating fluid introduction into microfluidic devices
US6524790B1 (en) 1997-06-09 2003-02-25 Caliper Technologies Corp. Apparatus and methods for correcting for variable velocity in microfluidic systems
US5869004A (en) 1997-06-09 1999-02-09 Caliper Technologies Corp. Methods and apparatus for in situ concentration and/or dilution of materials in microfluidic systems
US5882465A (en) 1997-06-18 1999-03-16 Caliper Technologies Corp. Method of manufacturing microfluidic devices
US5959291A (en) 1997-06-27 1999-09-28 Caliper Technologies Corporation Method and apparatus for measuring low power signals
US6001231A (en) 1997-07-15 1999-12-14 Caliper Technologies Corp. Methods and systems for monitoring and controlling fluid flow rates in microfluidic systems
US5876675A (en) 1997-08-05 1999-03-02 Caliper Technologies Corp. Microfluidic devices and systems
US5989402A (en) 1997-08-29 1999-11-23 Caliper Technologies Corp. Controller/detector interfaces for microfluidic systems
EP1009995A4 (en) 1997-09-02 2007-05-02 Caliper Life Sciences Inc Microfluidic system with electrofluidic and electrothermal controls
US5965410A (en) 1997-09-02 1999-10-12 Caliper Technologies Corp. Electrical current for controlling fluid parameters in microchannels
US6012902A (en) 1997-09-25 2000-01-11 Caliper Technologies Corp. Micropump
US5842787A (en) 1997-10-09 1998-12-01 Caliper Technologies Corporation Microfluidic systems incorporating varied channel dimensions
US5958694A (en) 1997-10-16 1999-09-28 Caliper Technologies Corp. Apparatus and methods for sequencing nucleic acids in microfluidic systems
US6074725A (en) 1997-12-10 2000-06-13 Caliper Technologies Corp. Fabrication of microfluidic circuits by printing techniques
US5948227A (en) 1997-12-17 1999-09-07 Caliper Technologies Corp. Methods and systems for performing electrophoretic molecular separations
AU2021099A (en) 1997-12-30 1999-07-19 Caliper Technologies Corporation Software for the display of chromatographic separation data
US6251343B1 (en) 1998-02-24 2001-06-26 Caliper Technologies Corp. Microfluidic devices and systems incorporating cover layers
US6100541A (en) 1998-02-24 2000-08-08 Caliper Technologies Corporation Microfluidic devices and systems incorporating integrated optical elements
US6123798A (en) 1998-05-06 2000-09-26 Caliper Technologies Corp. Methods of fabricating polymeric structures incorporating microscale fluidic elements
US6306590B1 (en) * 1998-06-08 2001-10-23 Caliper Technologies Corp. Microfluidic matrix localization apparatus and methods
WO2000009753A1 (en) 1998-08-11 2000-02-24 Caliper Technologies Corp. Methods and systems for sequencing dna by distinguishing the decay times of fluorescent probes
US6445682B1 (en) * 1998-10-06 2002-09-03 Vertical Networks, Inc. Systems and methods for multiple mode voice and data communications using intelligently bridged TDM and packet buses and methods for performing telephony and data functions using the same
WO2000043547A1 (en) 1999-01-20 2000-07-27 Northwestern University Dna mobility modifier
EP2177627B1 (en) 1999-02-23 2012-05-02 Caliper Life Sciences, Inc. Manipulation of microparticles in microfluidic systems
US6303343B1 (en) 1999-04-06 2001-10-16 Caliper Technologies Corp. Inefficient fast PCR
US6495104B1 (en) 1999-08-19 2002-12-17 Caliper Technologies Corp. Indicator components for microfluidic systems
ATE414171T1 (en) * 1999-08-27 2008-11-15 Matrix Technologies Corp METHOD FOR IMMOBILIZING OLIGONUCLEOTIDES ON SOLID SUPPORT MATERIAL
US20010035351A1 (en) * 2000-03-10 2001-11-01 Simpson Peter C. Cross channel device for serial sample injection
US6706162B1 (en) * 2000-09-25 2004-03-16 Applera Corporation High speed, high resolution compositions, methods, and kits for capillary electrophoresis

Cited By (141)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100233026A1 (en) * 2002-05-09 2010-09-16 Ismagliov Rustem F Device and method for pressure-driven plug transport and reaction
US11413615B2 (en) 2002-05-09 2022-08-16 The University Of Chicago Device and method for pressure-driven plug transport and reaction
US20110177609A1 (en) * 2002-05-09 2011-07-21 The University Of Chicago Device and method for pressure-driven plug transport
US20110174622A1 (en) * 2002-05-09 2011-07-21 The University Of Chicago Device and method for pressure-driven plug transport
US8304193B2 (en) 2002-05-09 2012-11-06 The University Of Chicago Method for conducting an autocatalytic reaction in plugs in a microfluidic system
US8329407B2 (en) 2002-05-09 2012-12-11 The University Of Chicago Method for conducting reactions involving biological molecules in plugs in a microfluidic system
US9329107B2 (en) 2002-05-09 2016-05-03 The University Of Chicago Device for pressure-driven plug transport comprising microchannel with traps
US9579622B2 (en) 2002-05-09 2017-02-28 The University Of Chicago Device and method for pressure-driven plug transport and reaction
US8273573B2 (en) 2002-05-09 2012-09-25 The University Of Chicago Method for obtaining a collection of plugs comprising biological molecules
US9592506B2 (en) 2002-05-09 2017-03-14 The University Of Chicago Method of crystallization in aqueous plugs flowing in immiscible carrier-fluid in microfluidic system
US10668471B2 (en) 2002-05-09 2020-06-02 The University Of Chicago Device and method for pressure-driven plug transport and reaction
US10562028B2 (en) 2002-05-09 2020-02-18 The University Of Chicago Device and method for pressure-driven plug transport and reaction
US11478799B2 (en) 2002-05-09 2022-10-25 The University Of Chicago Method for conducting reactions involving biological molecules in plugs in a microfluidic system
US20110177586A1 (en) * 2002-05-09 2011-07-21 The University Of Chicago Device and method for pressure-driven plug transport
US8889083B2 (en) 2002-05-09 2014-11-18 The University Of Chicago Device and method for pressure-driven plug transport and reaction
US9968933B2 (en) 2002-05-09 2018-05-15 The University Of Chicago Device and method for pressure-driven plug transport and reaction
US11278898B2 (en) 2002-05-09 2022-03-22 The University Of Chicago Method for conducting an autocatalytic reaction in plugs in a microfluidic system
US10532358B2 (en) 2002-05-09 2020-01-14 The University Of Chicago Device and method for pressure-driven plug transport and reaction
EP2278338A3 (en) * 2002-05-09 2012-09-26 The University of Chicago Device and method for pressure-driven plug transport and reaction
US20110176966A1 (en) * 2002-05-09 2011-07-21 The University Of Chicago Device and method for pressure-driven plug transport
US20110177494A1 (en) * 2002-05-09 2011-07-21 The University Of Chicago Device and method for pressure-driven plug transport
US10118174B2 (en) 2002-05-09 2018-11-06 The University Of Chicago Device and method for pressure-driven plug transport and reaction
EP2302389A1 (en) * 2002-05-09 2011-03-30 The University of Chicago Device and method for pressure-driven plug transport and reaction
US20110142734A1 (en) * 2002-05-09 2011-06-16 The University Of Chicago Device and method for pressure-driven plug transport
US11413614B2 (en) 2002-05-09 2022-08-16 The University Of Chicago Device and method for pressure-driven plug transport and reaction
US7932190B2 (en) 2002-08-30 2011-04-26 Caliper Life Sciences, Inc Flow control of photo-polymerizable resin
US20060121743A1 (en) * 2002-08-30 2006-06-08 Caliper Life Sciences, Inc. Flow control of photo-polymerizable resin
US7001853B1 (en) 2002-08-30 2006-02-21 Caliper Life Sciences, Inc. Flow control of photo-polymerizable resin
US11187702B2 (en) 2003-03-14 2021-11-30 Bio-Rad Laboratories, Inc. Enzyme quantification
US9448172B2 (en) 2003-03-31 2016-09-20 Medical Research Council Selection by compartmentalised screening
US10052605B2 (en) 2003-03-31 2018-08-21 Medical Research Council Method of synthesis and testing of combinatorial libraries using microcapsules
US20100210479A1 (en) * 2003-03-31 2010-08-19 Medical Research Council Method of synthesis and testing of cominatorial libraries using microcapsules
US9857303B2 (en) 2003-03-31 2018-01-02 Medical Research Council Selection by compartmentalised screening
US20060153924A1 (en) * 2003-03-31 2006-07-13 Medical Research Council Selection by compartmentalised screening
US11821109B2 (en) 2004-03-31 2023-11-21 President And Fellows Of Harvard College Compartmentalised combinatorial chemistry by microfluidic control
US9925504B2 (en) 2004-03-31 2018-03-27 President And Fellows Of Harvard College Compartmentalised combinatorial chemistry by microfluidic control
US9839890B2 (en) 2004-03-31 2017-12-12 National Science Foundation Compartmentalised combinatorial chemistry by microfluidic control
US20090197772A1 (en) * 2004-03-31 2009-08-06 Andrew Griffiths Compartmentalised combinatorial chemistry by microfluidic control
US20070092914A1 (en) * 2004-03-31 2007-04-26 Medical Research Council, Harvard University Compartmentalised screening by microfluidic control
US8252536B2 (en) 2004-06-29 2012-08-28 Wallac Oy Integrated nucleic acid analysis
US20060014185A1 (en) * 2004-06-29 2006-01-19 Wallac Oy Integrated nucleic acid analysis
US20110070585A1 (en) * 2004-06-29 2011-03-24 Wallac Oy Integrated nucleic acid analysis
US7776530B2 (en) * 2004-06-29 2010-08-17 Wallac Oy Integrated nucleic acid analysis
US9477233B2 (en) 2004-07-02 2016-10-25 The University Of Chicago Microfluidic system with a plurality of sequential T-junctions for performing reactions in microdroplets
US12097475B2 (en) 2004-07-02 2024-09-24 The University Of Chicago Microfluidic system
US20060003439A1 (en) * 2004-07-02 2006-01-05 Ismagilov Rustem F Microfluidic system
US8871444B2 (en) 2004-10-08 2014-10-28 Medical Research Council In vitro evolution in microfluidic systems
US11786872B2 (en) 2004-10-08 2023-10-17 United Kingdom Research And Innovation Vitro evolution in microfluidic systems
US20090197248A1 (en) * 2004-10-08 2009-08-06 President And Fellows Of Harvard College Vitro evolution in microfluidic systems
US9029083B2 (en) 2004-10-08 2015-05-12 Medical Research Council Vitro evolution in microfluidic systems
US9186643B2 (en) 2004-10-08 2015-11-17 Medical Research Council In vitro evolution in microfluidic systems
US9498759B2 (en) 2004-10-12 2016-11-22 President And Fellows Of Harvard College Compartmentalized screening by microfluidic control
US20090005254A1 (en) * 2004-10-12 2009-01-01 Andrew Griffiths Compartmentalized Screening by Microfluidic Control
US9328344B2 (en) 2006-01-11 2016-05-03 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US9534216B2 (en) 2006-01-11 2017-01-03 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US9410151B2 (en) 2006-01-11 2016-08-09 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US9273308B2 (en) 2006-05-11 2016-03-01 Raindance Technologies, Inc. Selection of compartmentalized screening method
US12091710B2 (en) 2006-05-11 2024-09-17 Bio-Rad Laboratories, Inc. Systems and methods for handling microfluidic droplets
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
US11351510B2 (en) 2006-05-11 2022-06-07 Bio-Rad Laboratories, Inc. Microfluidic devices
US9498761B2 (en) 2006-08-07 2016-11-22 Raindance Technologies, Inc. Fluorocarbon emulsion stabilizing surfactants
US9012390B2 (en) 2006-08-07 2015-04-21 Raindance Technologies, Inc. Fluorocarbon emulsion stabilizing surfactants
US20100078077A1 (en) * 2006-12-19 2010-04-01 Ismagilov Rustem F Spacers for Microfluidic Channels
US9017623B2 (en) 2007-02-06 2015-04-28 Raindance Technologies, Inc. Manipulation of fluids and reactions in microfluidic systems
US9440232B2 (en) 2007-02-06 2016-09-13 Raindance Technologies, Inc. Manipulation of fluids and reactions in microfluidic systems
US20100163109A1 (en) * 2007-02-06 2010-07-01 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US11819849B2 (en) 2007-02-06 2023-11-21 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US10603662B2 (en) 2007-02-06 2020-03-31 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US10675626B2 (en) 2007-04-19 2020-06-09 President And Fellows Of Harvard College Manipulation of fluids, fluid components and reactions in microfluidic systems
US10960397B2 (en) 2007-04-19 2021-03-30 President And Fellows Of Harvard College Manipulation of fluids, fluid components and reactions in microfluidic systems
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US10357772B2 (en) 2007-04-19 2019-07-23 President And Fellows Of Harvard College Manipulation of fluids, fluid components and reactions in microfluidic systems
US11224876B2 (en) 2007-04-19 2022-01-18 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US9068699B2 (en) 2007-04-19 2015-06-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US20100252118A1 (en) * 2007-04-19 2010-10-07 Seth Fraden Manipulation of fluids, fluid components and reactions in microfluidic systems
US11618024B2 (en) 2007-04-19 2023-04-04 President And Fellows Of Harvard College Manipulation of fluids, fluid components and reactions in microfluidic systems
US8016260B2 (en) 2007-07-19 2011-09-13 Formulatrix, Inc. Metering assembly and method of dispensing fluid
US20090020556A1 (en) * 2007-07-19 2009-01-22 Kabir James Mukaddam Metering assembly and method of dispensing fluid
US9090885B2 (en) 2007-07-26 2015-07-28 The University Of Chicago Co-incubating confined microbial communities
US20100227767A1 (en) * 2007-07-26 2010-09-09 Boedicker James Q Stochastic confinement to detect, manipulate, and utilize molecules and organisms
US20100317085A1 (en) * 2007-07-26 2010-12-16 Boedicker James Q Co-incubating confined microbial communities
US20110112503A1 (en) * 2008-06-04 2011-05-12 Ismagilov Rustem F Chemistrode, a plug-based microfluidic device and method for stimulation and sampling with high temporal, spatial, and chemical resolution
US8622987B2 (en) 2008-06-04 2014-01-07 The University Of Chicago Chemistrode, a plug-based microfluidic device and method for stimulation and sampling with high temporal, spatial, and chemical resolution
US11596908B2 (en) 2008-07-18 2023-03-07 Bio-Rad Laboratories, Inc. Droplet libraries
US10533998B2 (en) 2008-07-18 2020-01-14 Bio-Rad Laboratories, Inc. Enzyme quantification
US11534727B2 (en) 2008-07-18 2022-12-27 Bio-Rad Laboratories, Inc. Droplet libraries
US11511242B2 (en) 2008-07-18 2022-11-29 Bio-Rad Laboratories, Inc. Droplet libraries
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
US20100022414A1 (en) * 2008-07-18 2010-01-28 Raindance Technologies, Inc. Droplet Libraries
US20100186841A1 (en) * 2009-01-23 2010-07-29 Formulatrix, Inc. Microfluidic dispensing assembly
US8550298B2 (en) 2009-01-23 2013-10-08 Formulatrix, Inc. Microfluidic dispensing assembly
US8100293B2 (en) 2009-01-23 2012-01-24 Formulatrix, Inc. Microfluidic dispensing assembly
US20100187452A1 (en) * 2009-01-23 2010-07-29 Formulatrix, Inc. Microfluidic dispensing assembly
US8528589B2 (en) 2009-03-23 2013-09-10 Raindance Technologies, Inc. Manipulation of microfluidic droplets
US11268887B2 (en) 2009-03-23 2022-03-08 Bio-Rad Laboratories, Inc. Manipulation of microfluidic droplets
US9415392B2 (en) 2009-03-24 2016-08-16 The University Of Chicago Slip chip device and methods
US9464319B2 (en) 2009-03-24 2016-10-11 California Institute Of Technology Multivolume devices, kits and related methods for quantification of nucleic acids and other analytes
US10196700B2 (en) 2009-03-24 2019-02-05 University Of Chicago Multivolume devices, kits and related methods for quantification and detection of nucleic acids and other analytes
US9447461B2 (en) 2009-03-24 2016-09-20 California Institute Of Technology Analysis devices, kits, and related methods for digital quantification of nucleic acids and other analytes
US10543485B2 (en) 2009-03-24 2020-01-28 University Of Chicago Slip chip device and methods
US9493826B2 (en) 2009-03-24 2016-11-15 California Institute Of Technology Multivolume devices, kits and related methods for quantification and detection of nucleic acids and other analytes
US10370705B2 (en) 2009-03-24 2019-08-06 University Of Chicago Analysis devices, kits, and related methods for digital quantification of nucleic acids and other analytes
US9649631B2 (en) 2009-06-04 2017-05-16 Leidos Innovations Technology, Inc. Multiple-sample microfluidic chip for DNA analysis
US9067207B2 (en) 2009-06-04 2015-06-30 University Of Virginia Patent Foundation Optical approach for microfluidic DNA electrophoresis detection
US20110223605A1 (en) * 2009-06-04 2011-09-15 Lockheed Martin Corporation Multiple-sample microfluidic chip for DNA analysis
US9656261B2 (en) 2009-06-04 2017-05-23 Leidos Innovations Technology, Inc. DNA analyzer
US20110229897A1 (en) * 2009-06-04 2011-09-22 Lockheed Martin Corporation Optical approach for microfluidic DNA electrophoresis detection
US10520500B2 (en) 2009-10-09 2019-12-31 Abdeslam El Harrak Labelled silica-based nanomaterial with enhanced properties and uses thereof
US10837883B2 (en) 2009-12-23 2020-11-17 Bio-Rad Laboratories, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US9074242B2 (en) 2010-02-12 2015-07-07 Raindance Technologies, Inc. Digital analyte analysis
US9228229B2 (en) 2010-02-12 2016-01-05 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US10808279B2 (en) 2010-02-12 2020-10-20 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US11254968B2 (en) 2010-02-12 2022-02-22 Bio-Rad Laboratories, Inc. Digital analyte analysis
US8535889B2 (en) 2010-02-12 2013-09-17 Raindance Technologies, Inc. Digital analyte analysis
US11390917B2 (en) 2010-02-12 2022-07-19 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11635427B2 (en) 2010-09-30 2023-04-25 Bio-Rad Laboratories, Inc. Sandwich assays in droplets
US9562897B2 (en) 2010-09-30 2017-02-07 Raindance Technologies, Inc. Sandwich assays in droplets
US8961764B2 (en) 2010-10-15 2015-02-24 Lockheed Martin Corporation Micro fluidic optic design
US9364803B2 (en) 2011-02-11 2016-06-14 Raindance Technologies, Inc. Methods for forming mixed droplets
US11077415B2 (en) 2011-02-11 2021-08-03 Bio-Rad Laboratories, Inc. Methods for forming mixed droplets
US11747327B2 (en) 2011-02-18 2023-09-05 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11965877B2 (en) 2011-02-18 2024-04-23 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11168353B2 (en) 2011-02-18 2021-11-09 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US9150852B2 (en) 2011-02-18 2015-10-06 Raindance Technologies, Inc. Compositions and methods for molecular labeling
US11768198B2 (en) 2011-02-18 2023-09-26 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11754499B2 (en) 2011-06-02 2023-09-12 Bio-Rad Laboratories, Inc. Enzyme quantification
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US11898193B2 (en) 2011-07-20 2024-02-13 Bio-Rad Laboratories, Inc. Manipulating droplet size
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
US9322054B2 (en) 2012-02-22 2016-04-26 Lockheed Martin Corporation Microfluidic cartridge
US9988676B2 (en) 2012-02-22 2018-06-05 Leidos Innovations Technology, Inc. Microfluidic cartridge
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US11174509B2 (en) 2013-12-12 2021-11-16 Bio-Rad Laboratories, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11193176B2 (en) 2013-12-31 2021-12-07 Bio-Rad Laboratories, Inc. Method for detecting and quantifying latent retroviral RNA species
EP3092055A4 (en) * 2014-01-09 2017-08-09 The Board of Trustees of the Leland Stanford Junior University Simultaneous extraction and separation of rna and dna from single cells using electrophoretic techniques
US10750928B2 (en) 2014-01-09 2020-08-25 The Board Of Trustees Of The Leland Stanford Junior University Simultaneous extraction and separation of RNA and DNA from single cells using electrophoretic techniques
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions

Also Published As

Publication number Publication date
US20040045827A1 (en) 2004-03-11
US7521186B2 (en) 2009-04-21

Similar Documents

Publication Publication Date Title
US7521186B2 (en) PCR compatible nucleic acid sieving matrix
US7156969B2 (en) Microfluidic matrix localization apparatus and methods
US8841116B2 (en) Inline-injection microdevice and microfabricated integrated DNA analysis system using same
Kan et al. DNA sequencing and genotyping in miniaturized electrophoresis systems
Horsman et al. Forensic DNA analysis on microfluidic devices: a review
Zhang et al. Single-molecule DNA amplification and analysis using microfluidics
Novak et al. Single cell multiplex gene detection and sequencing using microfluidically-generated agarose emulsions
JP2020535951A (en) How to make a monodisperse emulsion
Njoroge et al. Integrated microfluidic systems for DNA analysis
Sassi et al. Rapid, parallel separations of D1S80 alleles in a plastic microchannel chip
Yeung et al. Integrated sample cleanup− capillary electrophoresis microchip for high-performance short tandem repeat genetic analysis
Dunn et al. PCR amplification and analysis of simple sequence length polymorphisms in mouse DNA using a single microchip device
JP2021534956A (en) Droplet formation induced by monodisperse particles from a stable jet
WO2021150426A1 (en) Efficient random access to dna-encoded data
Ng et al. Miniaturized platforms for the detection of single-nucleotide polymorphisms
Njoroge et al. Integrated continuous flow polymerase chain reaction and micro‐capillary electrophoresis system with bioaffinity preconcentration
Malic et al. Current state of intellectual property in microfluidic nucleic acid analysis
Hatori et al. Dual‐layered hydrogels allow complete genome recovery with nucleic acid cytometry
Xue et al. On-line nanoliter cycle sequencing reaction with capillary zone electrophoresis purification for DNA sequencing
Ugaz et al. Electrophoresis in microfluidic systems
Xie et al. Microchip-based capillary electrophoresis systems
Shandrick et al. Rapid microwell polymerase chain reaction with subsequent ultrathin‐layer gel electrophoresis of DNA
Bacheva et al. Selective extraction of biomolecules using a bidirectional flow filter
Giordano et al. Toward an integrated electrophoretic microdevice for clinical diagnostics
Kailasa et al. Miniaturized Capillary Electrophoresis for the Separation and Identification of Biomolecules

Legal Events

Date Code Title Description
AS Assignment

Owner name: CALIPER TECHNOLOGIES CORP., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MEHTA, TAMMY BURD;REEL/FRAME:012101/0832

Effective date: 20010715

STCB Information on status: application discontinuation

Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION